Characterization of splicing mechanisms by single-molecule fluorescence by Karunatilaka, Krishanthi Sanjeewani
Wayne State University
Wayne State University Dissertations
1-1-2011
Characterization of splicing mechanisms by single-
molecule fluorescence
Krishanthi Sanjeewani Karunatilaka
Wayne State University
Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations
Part of the Biochemistry Commons, Biophysics Commons, and the Molecular Biology
Commons
This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in
Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Karunatilaka, Krishanthi Sanjeewani, "Characterization of splicing mechanisms by single-molecule fluorescence" (2011). Wayne State
University Dissertations. Paper 243.
CHARACTERIZATION OF SPLICING MECHANISMS BY  
SINGLE-MOLECULE FLUORESCENCE 
by 
KRISHANTHI SANJEEWANI KARUNATILAKA 
DISSERTATION 
Submitted to the Graduate School  
of Wayne State University,  
  Detroit, Michigan  
in partial fulfillment of the requirements  
for the degree of 
DOCTOR OF PHILOSOPHY  
2011 
        MAJOR: CHEMISTRY (Biochemistry) 
        Approved by: 
          
        Advisor                          Date 
                                                            
 
 
 
 
         
  
ii 
 
DEDICATION 
 
This dissertation is dedicated to my loving parents and the Karunatilaka family who 
have supported and motivated me throughout my life.  
  
iii 
 
ACKNOWLEDGEMENTS 
 First and foremost, I would like to thank my advisor Professor David Rueda 
for his guidance and encouragement throughout my graduate studies. As a 
member of his first group of Ph.D. students, I really appreciate his immense 
support from the beginning to the end of my thesis work. I am also grateful for all 
his generous contributions of time, ideas and funding toward my research. I am 
thankful to my research committee members, Prof. Andrew Feig, Prof. Philip 
Cunningham and Prof. Tiffany Mathews for their feedback on my research as well 
as their valuable time spent reading the thesis and attending my research 
presentations. I am also thankful to our collaborators Prof. Anna Marie Pyle, Yale 
University, and Prof. Roland Sigel, University of Zurich, for their substantial time 
and continuous support that made my research carrier more productive.  
 I am thankful for all the present and past members of Rueda group, who 
have contributed in different ways at Wayne State University. I am truly grateful for 
Miriam Steiner, Chris Baker, Fardusee Ullah and Amanda Solem for their 
significant contributions toward my research. I am also grateful to Rui Zhao for his 
single-molecule microscopy support. Furthermore, I would like to especially thank 
Rui, Rajan, Amanda, Zhuojun, Elvin, Alfonso, Marcus, Gayan, Chandani, Hansini, 
Bishnu, Radek and Kyle for all their helpful discussions and for providing a 
productive environment to perform my studies.                  
 I would like to thank Prof. Christine Chow for allowing me to use 
instrumentation in her lab and for providing valuable advice for my research. I am 
  
iv 
 
also thankful to the RNA Club for the opportunities to discuss my research and to 
learn about other RNA research at Wayne State University. Additionally, I like to 
thank all the staff members in the department of Chemistry for their generous 
support during my studies.      
 I gratefully acknowledge all funding sources that made my research carrier 
more productive. I am thankful to the National Institutes of Health (NIH) and 
National Science Foundation (NSF) for funding this thesis work. I also thank 
Wayne State University for its financial support including the Graduate Dissertation 
Fellowship, which has allowed me to comfortably complete my dissertation.   
 Lastly, I would like to thank my family and friends for their immense support, 
love and encouragement. I owe my deepest gratitude to my loving parents for their 
continuous love, guidance and encouragement throughout my life. I am grateful for 
my brothers and sisters, who have supported me various ways to achieve my 
goals. I am also grateful for my fiancé, Kyle Vrtis, for his endless love and support 
he has given me to complete my thesis as well as for sharing all good and bad 
moments with me. Furthermore, I would like to express my gratitude to Kyle’s 
family for all their support during last two years.     
  
  
v 
 
TABLE OF CONTENTS 
Dedication ................................................................................................................ ii 
Acknowledgments................................................................................................... iii 
List of Tables........................................................................................................... ix 
List of Figures ..........................................................................................................x 
List of Abbreviations............................................................................................... xii 
CHAPTER 1: Introduction .......................................................................................1 
1.1 RNA and the origin of life ...................................................................................1 
1.2 Structure and function of RNA ...........................................................................1 
1.3 RNA folding........................................................................................................5 
1.3.1 RNA folding pathways.....................................................................................6 
1.3.2 Effect of metal ions on RNA folding .........................................................8 
1.3.3 RNA folding and protein cofactors ...........................................................9 
1.4 Ribozymes....................................................................................................10 
1.5 Group II Introns ............................................................................................12 
1.5.1 Structure of group II Introns ...................................................................13 
1.5.2 Group II Intron splicing...........................................................................17 
1.6 Folding of group II introns.............................................................................20 
1.7 Protein-mediated group II intron splicing......................................................24 
1.7.1 Structure and function of Mss116 ..........................................................25 
1.7.2 Mss116-mediated group II intron splicing mechanism...........................28 
1.8 Nuclear pre-mRNA splicing ..........................................................................29 
  
vi 
 
1.9 The spliceosome ..........................................................................................31 
1.9.1 Assembly of the spliceosome ................................................................32 
1.10 Spliceosomal U2-U6 snRNA complex........................................................34 
1.10.1 Structure of human and yeast U2-U6 snRNA complex .......................36 
1.11 Fluorescence-based detection of biomolecules .........................................38 
1.11.1 Fluorescence theory ............................................................................39 
1.11.2 Fluorescence Resonance Energy Transfer (FRET) ............................39 
1.11.3 Single-molecule fluorescence..............................................................42 
1.11.4 Fluorescence anisotropy......................................................................46 
1.12 Specific aims ..............................................................................................48 
CHAPTER 2: Materials and Experimental Methods ..............................................50 
2.1 Materials.......................................................................................................50 
2.2 Single-molecule analysis of Mss116-mediated group II intron folding .........51 
2.2.1 Preparation of DNA, RNA and protein samples.....................................51 
2.2.2 Characterization of Mss116 activity .......................................................52 
2.2.3 Single-molecule FRET experiments ......................................................53 
2.3 Single-molecule studies of human spliceosomal U2-U6 snRNAs................55 
2.3.1 RNA purification and labeling ................................................................55 
2.3.2 Steady-state FRET (ssFRET)................................................................55 
2.3.3 Single-molecule FRET (smFRET) .........................................................56 
2.4 An RNA Aptamer Based Purification System for Fluorophore Labeled 
Proteins ..............................................................................................................57 
  
vii 
 
2.4.1 RNA Synthesis and purification .............................................................57 
2.3.2 Fluorophore labeling of protein ..............................................................59 
2.3.3 Fluorescence anisotropy measurements...............................................59 
2.3.4 Affinity column protein purification assay...............................................61 
CHAPTER 3: Single-molecule Analysis of Mss116-mediated Group II Intron 
Folding ...................................................................................................................62 
3.1 Introduction...................................................................................................62 
3.2 Experimental design.....................................................................................66 
3.3 Results .........................................................................................................70 
3.3.1 Folding of group II introns alone requires high ionic strength ................70 
3.3.2 Mss116 facilitates group II intron folding in vitro....................................73 
3.3.3 ATP hydrolysis by Mss116 is required to form the native state .............81 
3.3.4 Folding dynamics depend on Mss116 and ATP ....................................85 
3.4 Discussion ....................................................................................................90 
3.5 Conclusions..................................................................................................94 
CHAPTER 4: Single-molecule Studies of Human Spliceosomal U2-U6 snRNAs .97 
4.1 Introduction...................................................................................................97 
4.2 Experimental design...................................................................................102 
4.3 Results .......................................................................................................104 
4.3.1 Mg2+-dependent structural dynamics by steady-state FRET ...............104 
4.3.2 Mg2+-dependent structural dynamics by single-molecule FRET..........106 
  
viii 
 
4.3.3 Single-molecule detection of the human U2-U6 complex with 
modifications.................................................................................................110 
4.3.4 Characterization of individual modifications in U2 stem I ....................112 
4.4 Discussion ..................................................................................................115 
4.5 Conclusions................................................................................................119 
CHAPTER 5: An RNA Aptamer Based Purification System for Fluorophore 
Labeled Proteins ..................................................................................................122 
5.1 Introduction.................................................................................................122 
5.2 Experimental design...................................................................................126 
5.3 Results and Discussion ..............................................................................128 
5.3.1 SRB-2 binds TAMRA with high affinity and specificity.........................128 
5.3.2 SRB-2 binding can be regulated by Mg2+ ions and EDTA...................130 
5.3.3 RNA aptamer affinity purification of a TAMRA labeled protein ............133 
5.4 Conclusions................................................................................................136 
CHAPTER 6: Conclusions and Future Directions ...............................................138 
References...........................................................................................................145  
Abstract................................................................................................................167 
Autobiographical Statement……………………………………………………….….170 
  
ix 
 
LIST OF TABLES 
CHAPTER 3 
Table 3.1: Peak centers, areas and peak heights..................................................77 
Table 3.2: Single-molecule folding dynamics of D135-L14 ribozyme. ...................87 
Table 3.3: The percentage of transitions between conformational states..............89 
 
CHAPTER 4 
Table 4.1: Difference between calculated free energy changes ..........................114 
 
 
  
x 
 
LIST OF FIGURES  
CHAPTER 1 
Figure 1.1: The central dogma of molecular biology................................................2 
Figure 1.2: Four basic types of nucleotides in RNA.................................................4 
Figure 1.3: Secondary structure of ai5γ group II intron ..........................................15 
Figure 1.4: Mechanisms of the group II intron splicing. .........................................18 
Figure 1.5: The proposed two-step folding pathway. .............................................22 
Figure 1.6: Structure of Mss116 DEAD-box protein...............................................26 
Figure 1.7: Eukaryotic nuclear pre-mRNA splicing reaction ..................................30 
Figure 1.8: The spliceosome assembly pathway. ..................................................33 
Figure 1.9: Structure of human and yeast U2-U6 snRNA complexes....................35 
Figure 1.10: Jablonski energy diagram..................................................................41 
Figure 1.11: Setup of TIRF single-molecule microscopy. ......................................45 
Figure 1.12: The principle of fluorescence anisotropy. ..........................................47 
CHAPTER 3 
Figure 3.1: The folding pathway of the D135-L14 ribozyme. .................................64 
Figure 3.2: Secondary structure of the Sc. D135-L14 ribozyme. ...........................67 
Figure 3.3: Single-molecule detection....................................................................69 
Figure 3.4: Effect of ionic strength on the folding dynamics. .................................72 
Figure 3.5: ATPase, unwinding and splicing activity of the Mss116. .....................74 
Figure 3.6: Mss116 promotes folding of group II introns........................................76 
  
xi 
 
Figure 3.7: The folding of group II introns at physiological conditions. ..................78 
Figure 3.8: Effect of substrate on the protein-mediated folding. ............................80 
Figure 3.9: Role of ATP in Mss116-mediated folding of group II introns. ..............82 
Figure 3.10: Effects of mutant Mss116 on group II intron folding dynamics. .........86 
Figure 3.11: Percentage of dynamic and static molecules. ...................................86 
Figure 3.12: Transition density plots from HMM analysis. .....................................88 
Figure 3.13: Mss116-mediated group II intron folding pathway. ............................93 
CHAPTER 4 
Figure 4.1: Structures of modified residues and U2 stem I..................................100 
Figure 4.2: Human U2-U6 snRNA complexs. ......................................................103 
Figure 4.3: Steady-state fluorescence .................................................................105 
Figure 4.4: Mg2+-dependent structural dynamics.................................................107 
Figure 4.5: The folding pathway of human U2-U6 complex.................................109 
Figure 4.6: Single-mocule analysis of the modified human U2-U6 complex........111 
Figure 4.7: Single-molecule FRET histograms of the modified constructs ..........113 
CHAPTER 5 
Figure 5.1: Selection of oligonucleotide aptamers by SELEX...…………………..125 
Figure 5.2: Structure of SRB-2 aptamer and fluorophores ..................................127 
Figure 5.3: Fluorescence anisotropy....................................................................129 
Figure 5.4: Effect of Mg2+ and EDTA concentrations on binding of SRB-2..........131 
Figure 5.5: RNA aptamer affinity purification of a TAMRA labeled protein. .........134 
  
xii 
 
LIST OF ABBREVIATIONS 
AMPPNP   Adenylyl-imidodiphosphate  
ATP     Adenosine-5'-triphosphate 
D135   Domains 1, 3 and 5 
DTT   Dithiothreitol 
EBS    Exon binding sites 
EDTA    Ethylenediamine-N,N,N',N'-tetraacetic acid 
FRET   Fluorescence resonance energy transfer 
IBS    Intron binding sites 
IEP   Intron-encoded proteins  
 
ISL     Intramolecular stem loop 
MOPS   3-morpholinopropane-1-sulfonic acid 
NMR    Nuclear magnetic resonance 
NTP    Nucleoside 5'-triphosphate 
PAGE   Polyacrylamide gel electrophoresis 
Sc.     Saccharomyces cerevisiae 
Sc.ai5γ   Yeast mitochondrial ai5γ group II intron 
snRNA   Small nuclear RNA 
snRNP    Small nuclear ribonucleoproteins 
TIRF    Total internal reflection fluorescence 
TRIS    2-amino-2-(hydroxymethyl)propane-1,3-diol 
1 
 
 
 
CHAPTER 1  
Introduction 
1.1 RNA and the origin of life 
 Gene expression is an essential biological process that converts genetic 
information to functional products in all domains of life. Regulation of gene 
expression is essential to maintain proper cellular activities in living organisms. As 
a general mechanism, gene expression mainly consists of two steps: transcription 
and translation (Fig. 1.1). Transcription is a highly regulated first step of gene 
expression that converts genetic information stored in deoxyribonucleic acid (DNA) 
to messenger ribonucleic acid (mRNA). Translation is a process that converts 
mRNA to functional protein with the help of macromolecular complexes known as 
the ribosomes. In contrast to protein coding genes, non-protein coding genes code 
for functional RNAs such as ribosomal RNA (rRNA) and transfer RNA (tRNA) as 
main gene products. In addition, some organisms use RNA to store their genetic 
information suggesting an important link between the RNA and the origin of life (1).  
1.2 Structure and function of RNA 
 RNA is an important biological macromolecule that shows high functional 
versatility in living organisms. In addition to its well-known function as an 
information carrier, it can play an important role in catalysis and regulation of gene 
expression in living cells.  
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Figure 1.1 The central dogma of molecular biology. The central dogma 
describes the flow of genetic information from DNA to functional proteins through 
RNA intermediates. This process has two main steps: transcription and translation. 
Genetic information stored in DNA is converted into pre-mRNA by transcription in 
the nucleus. After RNA processing/splicing pre-mRNA forms the mature mRNA. 
Translation converts mRNA into functional proteins using ribosomes in the 
cytoplasm.       
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 Although RNA molecules are only made of four types of basic nucleotides 
(Fig. 1.2), adenine (A), guanine (G), cytosine (C) and uracil (U), the ability of RNA 
molecules to fold into an infinite number of structures supports the functional 
diversity of these molecules. RNA consists of a long chain of nucleotides and each 
nucleotide contains a nitrogenous base, a ribose sugar, and a phosphate group. 
One of the major features of RNA that distinguishes it from DNA is the presence of 
a hydroxyl group at the 2’ position of the ribose sugar. The presence of this 
functional group makes RNA conformationally flexible. As a result, RNA can form 
various secondary, tertiary and quaternary structures to perform different functions 
in cells.      
 RNA can perform an efficient regulatory role in living cells. Regulatory 
RNAs, including micro RNAs, small-interfering RNAs and small non-coding RNAs 
can regulate gene expression by various mechanisms either by direct translational 
suppression or by degradation of messenger RNA in cells (2-4). Riboswitches are 
one of the recently identified regulatory RNAs, which can regulate gene 
expression at both the transcriptional and the translational level providing more 
evidence for different roles of RNA at various stages in living cells (5,6).  
In addition to a regulatory role, RNA can act as a catalyst in various 
biological processes. More than two decades ago, Cech and Altman first 
discovered the catalytic nature of RNA by demonstrating that RNA molecules have 
a unique ability to perform chemical reactions in the absence of proteins (7,8).  
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Figure 1.2 Four basic types of nucleotides in RNA. Adenine (A), Guanine (G), 
Cytosine (C) and Uracil (U). Each unit consists of a nitrogenous base and a ribose 
sugar. G forms Watson-Crick base pairs with C, and A base pairs with U. 
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The catalytic ability of RNA was further confirmed with the recognition of 
RNA as a primary participant in two vital biological processes: splicing and 
translation. The spliceosome, a multi-megadalton ribonucleoprotein complex 
consisting of five RNAs and over 150 proteins, catalyzes nuclear pre-mRNA 
splicing mainly through spliceosomal RNAs (9-13). The ribosome is another 
essential multi-megadalton ribonucleoprotein complex, which utilizes RNA 
components to catalyze mRNA translation in all living organisms (14-16). 
 In summary, RNA has the ability to store genetic information, and it can act 
as an enzyme to catalyze biological reactions supporting an interesting hypothesis 
called the “RNA world” (1). According to the RNA world hypothesis, the world was 
initially filled with life based on RNA and it evolved to become a modern DNA and 
protein world.       
1.3 RNA folding 
In order to perform complex biological functions, an RNA strand must adopt 
a precise three-dimensional conformation in living organisms. Although RNA 
molecules are mostly comprised of only four basic nucleotides, folding of RNA can 
be as complicated as that of proteins, which are composed of 20 different amino 
acids. However, the mechanisms by which RNA can fold into active structures 
consist of the secondary and tertiary interactions are obscured in most biologically 
essential systems.  
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1.3.1 RNA folding pathways  
 Folding of a linear RNA strand into a compact active structure is a key 
requirement to ensure the proper function of mature RNA in cells. RNA folding is a 
hierarchical process and typically contains two main stages: formation of the 
secondary structure and formation of the highly compact tertiary structure. 
Formation of the secondary structure mostly depends on the Watson-Crick (A:U 
and G:C) base paring between specific regions of the primary sequence and it can 
be stimulated by any group that has the ability to compensate the electrostatic 
penalty created from polyanionic RNA backbones in a close proximity. Therefore, 
monovalent cations, divalent cations, basic proteins and the other cationic 
molecules can facilitate the formation of RNA secondary structures by neutralizing 
the negative charges of RNA backbones (17-23). RNA mainly comprises of four 
basic secondary structural elements: helices, loops, bulges and junctions (24-26). 
These secondary structural elements, alone or combining with each other, 
promote the formation of specific structural elements such as stem-loops, 
tetraloops and pseudoknots that are directly involved in various biological 
functions (24-26).  
 In the final stage of RNA folding, the secondary structure collapses into a 
compact tertiary structure allowing duplex stacking and long-range intramolecular 
interactions between bases and backbone residues of RNA. In addition to the 
Watson-Crick base pairs, wobble and Hoogsteen base pairs can also present in 
the tertiary structure of functional RNAs. Unlike secondary structure, the formation 
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of tertiary structure usually requires divalent cations such as magnesium ions 
(19,23,27). The formation of RNA tertiary structure generally depends on several 
factors: 1) RNA sequence, 2) density of metal ions, 3) concentration of metal ions, 
4) temperature, and 5) cofactors such as RNA binding proteins and polyamines. 
Therefore, individual RNA molecules can exhibit specific folding pathways under 
different reaction conditions providing evidence for a broad set of different RNA 
folding mechanisms.   
  RNA has a dynamic nature, which causes difficulties in defining a unique 
pathway for folding of large RNA molecules. Since RNA can be misfolded and 
trapped in stable inactive conformations, formation of the native conformations are 
highly challenging and leads to a common RNA folding problem (28). According to 
thermodynamic studies of the folding landscape (28,29), the native conformation 
contains the minimum free energy making it more stable than other inactive, 
misfolded conformations.  
Because of the rugged nature of the folding potential energy landscape, 
RNA exhibits complex kinetic pathways with multiple transient intermediates 
before reaching the active conformation. Interactions with protein co-factors and 
metal ions can influence the stability of these intermediates by changing the RNA 
folding energy landscapes. Therefore, protein cofactors such as chaperones and 
metal ions can play an essential role in RNA folding.   
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1.3.2 Effect of metal ions on RNA folding  
 Negatively charged phosphate groups in the backbone make RNA a 
charged molecule (polyanion) under physiological conditions and thus affect the 
formation of a compact structure. Positively charged groups are essential to 
screen these negative charges to promote RNA folding into complex three-
dimensional structures.   
  Cations, monovalent and divalent, are major components required in RNA 
folding (17-19,23,30). Monovalent metal ions such as K+ and Na+ mainly contribute 
to the nonspecific electrostatic stabilization of the RNA backbone (18-20,30). 
Therefore, these ions play a major role in the formation of RNA secondary 
structures. The formation of highly compact tertiary structure requires specific 
electrostatic interactions of dehydrated higher valency metal ions such as Mg2+ for 
correct positioning of groups in space (19,23,27). In addition to higher valency 
ions, specific monovalent ions also rarely perform the similar behavior (18,31).   
 In addition to direct participation in RNA folding, metal ions are also 
required for RNA catalysis (17,32,33). During RNA-catalyzed reactions, metal ions 
can act as cofactors to promote efficient reaction catalysis. Cations can mediate 
the chemical reactions by activation of the nucleophile, stabilization of the 
transition state and protonation of the leaving group (34). As a result, most 
catalytic RNAs require divalent metal ions such as Mg2+ in the active site to 
perform catalytic reactions.       
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 In accordance with the chemical structure, RNA contains a number of metal 
ion binding sites. In addition to unprotonated atoms in the bases, atoms in the 
phosphodiester linkage provide specific sites to interact with metal ions. Since the 
coordination affinity between metal ions and RNA is comparatively low, binding of 
metal ions with RNA is generally dynamic (34). Although, both monovalent and 
divalent metal ions are essential to regulate RNA structure and function, proteins 
and some positively charged molecules can replace metal ions from RNA and 
promote the formation of higher order structures.       
1.3.3 RNA folding and protein cofactors  
 Proteins can interact with RNA specifically or non-specifically to assist 
folding of RNA into an active conformation in cells (22,35-37). Based on the 
general mechanism, these proteins can be divided into four main groups: 1) 
specific RNA-binding proteins, 2) RNA chaperones, 3) RNA annealers and 4) RNA 
helicases. Specific RNA-binding proteins are basic proteins that can mediate RNA 
folding by interacting with specific sequence or structure of RNA. Furthermore, 
these proteins promote RNA folding through stabilization of intermediate 
conformations or the functionally active tertiary structure (38).    
 In contrast, some proteins bind RNA transiently and non-specifically to 
promote the formation of the active conformation by resolving non-functional 
kinetic traps (28,35). These proteins are broadly defined as RNA chaperones and 
are involved in various biological processes including regulation of gene 
expression, RNA export and assembly of ribonucleoprotein (RNP) complexes. 
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RNA chaperones disrupt RNA-RNA interactions and unfold the RNA structure. 
However, this process does not depend on ATP binding and hydrolysis (22).  
 RNA annealers accelerate the annealing of unstructured RNAs by 
molecular crowding (39). Binding of these proteins with complementary RNAs 
increases the local concentration, thereby increasing the frequency of interactions 
between RNAs to promote the annealing process. Interestingly, some RNA 
annealers alter the RNA conformation after binding to enhance the inter-molecular 
interactions of RNA (40).     
 RNA helicases are members of the DEAD-box family of proteins that can 
mediate the rearrangement of structured RNAs using energy derived from ATP 
hydrolysis (41,42). Most of RNA helicases are non-processive proteins, thus they 
unwind short RNA duplexes (22). In contrast to RNA chaperones, RNA helicases 
promote remodeling of RNP complexes based on the RNA-dependent ATPase 
activity.   
1.4 Ribozymes 
 RNA molecules that catalyze chemical reactions in the absence of proteins 
by forming active tertiary structures are known as catalytic RNAs or ribozymes 
(43,44). Functionally, ribozymes are very important and they can act as biosensors 
and therapeutic agents; furthermore they can play an important role in gene 
discovery (45-48). Because of this unique catalytic ability, ribozymes are ideal 
model systems to study the relationship between structure and function of RNA 
(36).  
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  Catalytic RNA was first recognized independently by Thomas Cech and 
Sydney Altman in the 1980s with Tetrahymena group I introns and bacterial 
RNase P, respectively (7,8). Since then, a number of studies have been 
conducted to discover more naturally occurring catalytic RNAs ranging from small 
catalytic RNAs such as the hairpin ribozyme to large catalytic RNAs such as group 
I and group II introns (36,43,44). In addition to these ribozymes, spliceosomal and 
ribosomal RNAs associated in large ribonucleoprotein complexes also provide 
more evidence for catalytic ability of RNA.  
 Ribozymes are primarily classified into two groups based on their size and 
mechanisms: small ribozymes and large ribozymes. The hairpin ribozyme, the 
hammerhead ribozyme, the hepatitis delta virus (HDV) ribozyme and the Varkud 
Satellite (VS) ribozyme are some of the best-characterized naturally occurring 
small ribozymes. Most of these small ribozymes contain less than 200 nucleotides 
and catalyze the site-specific cleavage of the backbone in a single stranded region 
of the RNA molecule. Although small ribozymes use a common chemical reaction 
mechanism to cleave the phosphodiester bond by generating a 2'-3'-cyclic 
phosphate and a product with a 5'-OH terminus (44), the folding and cleavage 
pathways of these molecules differ based on the length of the RNA strand and the 
requirement of metal ions.  
 In contrast to small ribozymes, large ribozymes are structurally diverse and 
the length of RNA strand can vary from ~100 to ~3000 nucleotides. Nuclear 
ribonuclease (RNase) P, group I introns and group II introns are well-studied 
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examples of large ribozymes in nature. In addition to the size, large ribozymes 
greatly differ from small ribozymes in the catalytic activity. RNase P is an 
endoribonuclease, which site specifically cleaves precursor RNAs such as tRNA 
and 5S rRNA. RNase P associates with protein for its function and forms an 
essential RNP complex. Group I and group II introns belong to self-splicing introns 
and are necessary for the removal of non-coding sequences (introns) from coding 
sequences (exons) to form mature RNA for expression of specific proteins.  
 The cleavage reactions of large ribozymes are different from small 
ribozymes and they require external or distal nucleophiles. RNase P uses a 
hydroxyl group of a water molecule as an attacking nucleophile and generates 
products containing a 5'-phosphate and a 3'-OH after hydrolytic cleavage of the 
RNA(49). Although the cleavage reaction of both group I and II introns consists of 
two transesterification steps, group I introns use an external GTP and group II 
introns use a 2’-OH of an internal adenosine to attack the 5’ splice site to initiate 
the first step of the splicing reaction. During the second step, the 3’-OH of the 5’ 
exon attacks the 3’ splice site and joins the two exons together forming a product 
with a 5'-phosphate and a 3'-OH (50,51).              
1.5 Group II Introns 
 Self-splicing introns are large RNA molecules that are able to catalyze their 
own excision from a pre-mRNA while covalently joining the flanking exon 
sequences. Group II introns are one of the largest natural self-splicing ribozymes 
(400-1000 nt) and they were initially identified in the organellar genomes of lower 
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eukaryotes and plants (52). However, bacterial genomic sequencing studies 
revealed that group II introns are widely distributed in bacteria suggesting group II 
introns may have evolved from the prokaryotic world (53). Furthermore, similarities 
between structures and catalytic mechanisms suggest that group II introns share a 
common ancestor with eukaryotic nuclear spliceosomal introns (54,55). 
 Group II introns have been found within protein coding mRNA as well as 
tRNA and rRNA genes. Although group II introns are important for expression of 
housekeeping genes in cells, bacterial group II introns can behave as mobile 
genetic elements and can be involved in genome diversification of bacteria 
(53,56). Interestingly, some group II introns contain an open reading frame (ORF) 
that encodes a protein. These intron-encoded proteins (IEP) can either facilitate 
intron splicing by stabilizing RNA tertiary structure or promoting site-specific 
insertion of group II introns into genomic DNA in bacteria (52,56).  
1.5.1 Structure of group II Introns  
Based on the secondary structure, group II introns can be classified into 
three major subgroups: group IIA, group IIB and group IIC. Group IIA and IIB 
introns are different from each other based on the location of exon binding site 2 
(EBS2), the length and composition of interdomain joiners and the tertiary 
interactions involved in recognition of the 3’ splice site (57,58). Group IIC introns 
are significantly different from group IIA and IIB introns. Introns belonging to the 
group IIC family are small in size and exhibit simple secondary structures (58). 
Despite the diversity in primary sequences, group II introns share a highly 
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conserved secondary structure (Fig. 1.3) that consists of six domains (D1-D6) 
radiating from a central core (59).  
Domain 1 is the largest intronic domain and serves as a scaffold for 
assembly of the other domains (60). D1 contains the exon-binding sites (EBS) and 
recognizes the 5’-exon (EBS1-IBS1 & EBS2-IBS2) and the 3’-exon (EBS3-IBS3) 
through base pairing interactions with intron-binding sites (IBS). According to 
structural studies conducted with the ai5γ group IIB intron (Fig. 1.3), derived from 
the Saccharomyces cerevisiae mitochondrial cox1 gene, D1 forms intra-domain 
tertiary interactions (α-α' & β- β') as well as long range inter-domain tertiary 
interactions with D2 (θ-θ') and D5 (κ-κ', ζ- ζ' and λ-λ'). The long range intra-domain 
interaction α-α' facilitates the binding of 5’-exon (60) as well as playing a major role 
in intron folding (61). Interactions κ-κ' and ζ- ζ' between D1 and D5 are important 
for D5 docking (62,63) and the interaction λ-λ' is directly involved in catalysis by 
facilitating the positioning of D5 close to 5’ splice site (64). Conversely, the 
tetraloop-receptor interaction θ-θ' between D1 and D2 is involved in the 
stabilization of the native structure rather than directly participating in catalysis 
(65).   
  D2 and D3 are not essential for group II intron function, but the presence of 
these domains enhances catalytic efficiency (66,67). Although D2 lacks 
phylogenetic conservation, it can interact with both D1 (θ-θ') and D6 (η-η') through 
inter-domain interactions and enhance the stability of the tertiary structure (65).  
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Figure 1.3 Secondary structure of Saccharomyces cerevisiae mitochondrial 
ai5γ  group II intron (Sc. ai5γ). Six domains are numbered from D1-D6 and are 
arranged around a central core. Tertiary interactions are indicated by Greek letters 
in blue. Exon binding sites (EBS1, EBS2 and EBS3) and intron binding sites (IBS1 
and IBS2) are shown in magenta. The branch point adenosine residue that is 
essential for branching pathway of intron splicing is shown in red. The black dot 
close to the 5’ end represents the splice site of the group II intron (68). 
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D3 forms tertiary contacts with D5 (µ-µ') and acts as a catalytic effector 
during splicing reaction (60). The most variable domain in the intron is D4, which 
contains an open reading frame (ORF) for a multifunctional intron-encoded protein 
(IEP), maturase. IEPs of organellar introns are important for in vivo folding of the 
group II intron RNA into a catalytically active tertiary structure (54). However, IEPs 
in bacteria mainly facilitate the mobility of introns (56). According to a recent group 
II intron crystal structure, D4 points away from the intron active site to 
accommodate the comparatively large ORF without affecting the catalysis (59).  
The most highly conserved region of the intron is D5, and it forms the 
catalytic center of the group II intron (54). Although D5 is a small stem loop 
structure (34 nt), it forms the network of tertiary contacts by interacting with the D1 
and D3 (Fig. 1.3). Domain 5 docks onto the D1 scaffold through interactions 
between D1 and D5 (κ-κ' and ζ- ζ') as described (62,63). Therefore, D5 is highly 
shielded from solvent except the region close to D6. As the most essential part of 
the intron, D5 consists of several groups that are important for the catalytic 
reaction including the catalytic triad (5’ -AGC), the tetra loop and the AC bulge. 
The catalytic triad, the most conserved region of D5, interacts with nucleotides in 
the linker between D2 and D3 (J2/3) and forms the triple helix structure (57). 
Therefore, this interaction merges two of the most essential parts together to 
promote the catalytic reaction of group II introns. Structural and mechanistic 
comparison between the spliceosome and group II introns indicates many 
similarities between D5 and the U6 snRNA in the spliceosome (55). 
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Domain 6 is important for the branching pathway of group II intron splicing 
(69). It contains the conserved branch point adenosine residue, which acts as a 
nucleophile during the first step of splicing reaction. D6 forms the tertiary contact 
with D2 (η-η') and facilitates the branch point docking on the coordination loop in 
D1 (nucleotides 222-229 and 368-370) (70). According to biochemical studies of 
the ai5γ group II intron, D1 and D5 are the only domains strictly required for the 
minimal catalytic function in group II introns (52,71).  
1.5.2 Group II Intron splicing 
 Group II introns can self-splice following two different reaction pathways: 
the branching pathway and the hydrolytic pathway (Fig. 1.4). Mechanisms of both 
group II intron splicing reactions consist of two consecutive transesterification 
steps (72,73). The branching pathway involves the branch point residue or the 
highly conserved adenosine located in a bulge of D6 as a nucleophile. In contrast, 
the hydrolytic pathway employs a solvent water molecule or a hydroxyl ion as a 
nucleophile to initiate the splicing reaction. The branching pathway is the most 
common two-step splicing mechanism in group II introns. The 2’-OH of the branch 
point adenosine initiates the first step of branching reaction by attacking the 5’ 
splice site. During the second step, the 3’-OH of the 5’ exon attacks the 3’ splice 
site and ligates the two exons together while releasing the intron as a lariot 
intermediate with a 2’–5’ phosphodiester bond (74).  
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Figure 1.4 Mechanisms of group II intron splicing. a. Schematic representation 
of the branching pathway b. Schematic representation of the water-mediated 
hydrolytic pathway. c. Group II intron cleavage mechanism. The attacking 
nucleophile can be an internal 2'-OH of adenine (Branching pathway) or a water 
molecule (Hydrolytic pathway). The cleavage reaction produces a 5'-phosphate 
and a 3'-hydroxyl terminus. Nu - nucleophile.  
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Both steps of the group II intron splicing are readily reversible (75,76). 
Interactions between intron-exon binding sites (IBS-EBS) are essential for 
substrate recognition as well as for proper positioning of different groups to 
mediate the splicing reaction. Alternatively, the hydrolytic pathway initiates the first 
step of splicing using an external hydroxyl ion or a water molecule as a 
nucleophile (73,77). The second step of splicing reaction ligates the 5’ and 3’ 
exons together and releases the linear intron providing an irreversible splicing 
reaction (Fig. 1.4). 
As mobile genetic elements, group II introns can be inserted into specific 
sites of the genome by several mechanisms (53,56). Intron-encoded proteins or 
maturases are essential to mediate the mobility of introns. In order to perform this 
function, maturases contain several parts including an endonuclease (EN) domain 
and a reverse transcriptase (RT) domain (53). Reterohoming is the most efficient 
mobile pathway of group II introns, which occurs through a target DNA-primed 
reverse transcription (TPRT) mechanism (78). A ribonucleoprotein complex 
containing the excised intron RNA lariot and the reverse transcriptase (RT) 
encoded by the intron ORF is essential to mediate the homing process. According 
to the general retrohoming mechanism, first the intron lariot reverse splices directly 
into a target site of the DNA sense strand. Reverse transcriptase then cleaves the 
opposite DNA strand at a specific site and forms the cDNA of the inserted intron 
RNA through reverse transcription using the 3’ end of the cleaved strand as a 
primer. Finally, the cDNA copy of the intron is integrated into the genome by 
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recombination or repair mechanisms (56,78). Retrotransposition is another mobile 
pathway of group II introns that occurs at low frequency in organisms (53).  
Retrotransposition or ectopic transposition occurs by the insertion of intron 
RNA into nonallelic sites of the genome. There are two main proposed 
mechanisms for transposing intron RNA into ectopic sites. One mechanism 
involves reverse splicing of the intron RNA directly into a noncognate DNA target 
site. The second mechanism involves the insertion of intron RNA into nonallelic 
sites through an RNA intermediate (53). This mechanism involves reverse splicing 
of the intron into a site of the RNA followed by reverse transcription and cDNA 
integration through homologous recombination.   
1.6 Folding of group II introns 
 In order to perform catalysis, large multi-domain group II intron RNA must 
fold into the correct native conformation. Folding of large RNA molecules into 
functionally active conformations is a highly complex process. Some RNA 
molecules exhibit “smooth” folding pathways that consist of slow and direct folding 
of RNA into the native conformation (79,80). On the other hand, many large RNA 
molecules fold into the native conformation through “rugged” folding pathways with 
one or more stable misfolded intermediates or kinetic traps (81,82).  
 The folding pathway of group II introns has been extensively studied over 
the last decade using the Sc. ai5γ group II intron. The D135 ribozyme (618 nt), 
which is derived from the yeast ai5γ group II intron, is one of the best-
characterized model systems for RNA catalysis. D135 lacks domain 6, and 
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domains 2 and 4 are shortened to hairpins, but it contains the original sequence of 
domains 1, 3 and 5 to retain catalytic activity (83).  As a result, D135 can undergo 
multiple hydrolytic cleavage reactions with a short substrate (17/7 substrate RNA), 
which consists of the IBS1, IBS2 and the cleavage site of the 5'-exon (84). Since 
group II introns can self-splice efficiently under high salt conditions (500 mM KCl, 
100 mM MgCl2) at 42°C, folding studies of the D135 RNA were primarily 
performed under these optimal in vitro splicing conditions (68,80).  
 Initial D135 folding studies were conducted using hydroxyl radical 
footprinting assays, which revealed the presence of solvent-inaccessible regions 
consistent with the tertiary contacts providing evidence for a compact tertiary 
structure (85). The global compaction of D135 was further characterized and two 
main collapsed states were initially identified using native gel analysis and 
equilibrium ultracentrifugation (80,83). A partially collapsed state with defined 
secondary structure that forms in the presence of K+ ions is referred to as the 
unfolded state. The highly compact structure that forms after addition of Mg2+ 
represents the folded state. In addition to that, ultracentrifugation studies revealed 
the Mg2+ dependency of global compaction comparable to that of the hydroxyl 
radical footprinting studies (KMg ~ 20 mM) (83,86). Urea denaturation studies have 
shown that the native state can unfold reversibly and both folding and unfolding 
reactions of D135 have similar thermodynamic parameters. Taken together, these 
structural studies proposed that the D135 RNA folds into the native conformation 
with an apparent two-step folding mechanism as shown in Figure 1.5 (80,86).  
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Figure 1.5 The proposed two-step folding pathway of the Sc. D135-ai5γ  
group II intron. Domain 1 is shown in blue and purple, domain 3 is shown in 
green and domain 5 is shown in orange. The folding pathway of the group II intron 
consists of three structural conformations: U – unfolded state, I – intermediate 
state and N – native state. Adapted from reference 80. 
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Further characterization of ai5γ-derived RNA constructs suggested the 
folding of D1 is a rate limiting step of D135 folding and it requires comparatively 
high Mg2+ concentration (80). Therefore, these D135 folding studies suggest the 
presence of a transient on-pathway folding intermediate consistent with the folding 
of other large RNA molecules. Although the D135 folding pathway consists of a 
slow folding rate (kobs ~1 min
-1), there was no experimental evidence to support the 
presence of kinetic traps (83,85).  
Specific atoms and functional groups that are critical for compaction of the 
D135 ribozyme were identified with nucleotide analog interference mapping 
(NAIM) (61). According to these mapping data, functional groups that are essential 
for D135 compaction are located in a small region of domain 1 that contains both 
D5 and D6 docking sites. Therefore, proper positioning of this element may trigger 
the folding of the entire intron into a compact structure.  
 In order to understand the function of group II introns in vivo, it is essential 
to characterize the intron RNA under native conditions.  Folding studies of the ai5γ 
group II introns in near-physiological conditions (1 mM MgCl2, 100 mM KCl at 
30°C) showed similar folding pathway as in optimal splicing conditions. However, 
the observed compaction of RNA is two orders of magnitude slower than that 
under optimal conditions (87). Furthermore, under low Mg2+ concentrations, D1 of 
group II introns slowly collapses to form the near-native state, an on-pathway 
folding intermediate with a partially compact structure, which can be converted into 
the native state by increasing the concentration of magnesium ions (87). Since the 
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native state is not stable under near-physiological conditions, the group II intron 
folding pathway requires high ionic strength or protein cofactors for extra 
stabilization of RNA structures.       
1.7 Protein-mediated group II intron splicing 
 Group II introns can self-splice independently in vitro in the presence of 
high ionic strength and elevated temperatures. However, in vivo splicing of group II 
introns requires proteins to mediate RNA folding into a catalytically active 
structure. Intron-encoded proteins or maturases are the major proteins involved in 
the splicing of mobile group II introns. These proteins stabilize the active structure 
of group II introns after binding specifically with the intron RNA (53). Aside from 
intron-encoded proteins, several host-encoded proteins have been genetically 
identified as group II intron splicing factors. These protein factors can function 
individually or cooperate with other proteins to promote group II intron splicing 
(52).  
 Group II intron splicing factors promote intron splicing by stabilizing RNA 
folding intermediates and/or by resolving non-native structures known as “kinetic 
traps” in the RNA folding pathway by acting as RNA chaperones (88-90). In 
addition to mediating efficient splicing of introns, host-encoded splicing factors can 
also participate in other cellular activities. As a result, it is challenging to 
understand the exact mechanism of protein-mediated group II intron splicing by 
indirect biochemical approaches.    
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1.7.1 Structure and function of Mss116   
Mss116, mitochondrial splicing system 116, is a host-encoded protein 
required for efficient splicing of all mitochondrial (mt) introns in yeast (88-92). It 
was first identified in a genetic screen as a nuclear gene that affects the 
mitochondrial electron transport chain of yeast. As a member of the DEAD-box 
protein family, Mss116 exhibits an RNA-dependent helicase activity required for 
structural rearrangements of RNA or RNP complexes. Mss116 belongs to the 
DExH/D subfamily, which contains ATP-dependent nucleic acid remodeling motors 
required for several cellular processes including translation, ribosome assembly, 
RNA splicing and RNA degradation. Based on conserved signature motifs, 
Mss116 can be further classified as a member of the helicase superfamily 2 (SF2) 
that shows RNA binding, ATPase, RNA unwinding and remodeling activities.  
 The structure of Mss116 DEAD-box protein (Fig. 1.6) has several important 
parts including a helicase core, a short N-terminal extension (NTE), mitochondrial 
targeting sequence (Mt), an α-helical C-terminal extension (CTE) and a basic tail 
(91). Comparable to other DEAD-box proteins, the helicase core of this protein 
contains two RecA-like domains (D1 and D2) joined by a flexible linker. Both C-
terminal and N-terminal domains of the helicase core consist of several conserved 
motifs that are required for RNA and ATP binding as well as for interdomain 
contacts. The motifs I and II are highly conserved regions of Mss116 (are also 
known as the Walker A and the Walker B, respectively).  Walker B consists of the 
conserved amino acids D-E-A-D that give the name to this protein family.  
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Figure 1.6 Structure of Mss116 DEAD-box protein. a. Schematic structure of 
Mss116 protein consisting of two RecA folds (cyan and green), an arginine rich C-
terminal extension (purple) and an N-terminal extension (white). The helicase core 
of Mss116 consists of nine conserved motifs that are important for RNA and ATP 
binding. b. Crystal structure of Mss116 containing two domains in the helicase 
core and C-terminal extension in the presence of single stranded RNA (orange) 
and AMPPNP (red), a non-hydrolysable ATP analog. Reproduced from reference 
(91), Copyright (2009), with permission from Elsevier.    
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According to recently published Mss116 crystal structures, RNA binds to a 
basic cleft perpendicular to the interface between two domains, and a non-
hydrolysable ATP analog – AMPPNP (Adenylyl-imidodiphosphate) binds onto the 
opposite side (91). Binding of RNA and ATP changes the conformation of the 
helicase core from the open state to the closed state as indicated in the crystal 
structures. The α-helical C-terminal extension is another essential part of the 
Mss116 that stabilizes the structure of the helicase core. It has been shown that 
point mutations within this region decrease RNA binding affinity and ATPase 
activity. 
The crystal structure of Mss116 confirms these findings and indicates that 
CTE contributes to the RNA binding by extending the RNA-binding side of domain 
2 (91). The C-terminal extension is followed by the basic tail, which is predicted to 
be an unstructured region of the Mss116. Deletion of the basic tail decreases the 
RNA binding affinity; therefore, it has been proposed that the basic tail of Mss116 
may provide an additional RNA binding site for proper functioning of proteins.  
Overall, these findings have suggested that the helicase core of Mss116 
acts together with the basic C-terminal to perform its functions. Properties of 
Mss116 have been characterized by various biochemical studies over the last few 
years (88,89,93,94). As a DEAD-box protein, Mss116 can hydrolyze ATP upon 
binding of RNA and facilitates the unwinding of short RNA duplexes without 
apparent directionality (89). Similar to other members of the DEAD-box family, 
Mss116 is nonprocessive and exhibits comparable RNA-dependent ATPase 
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activity. In contrast to other RNA helicases (95), Mss116 unwinds short duplexes 
by local strand separation rather than by translocation along RNA duplexes (93). 
However, recent studies have shown that DEAD-box protein-mediated RNA 
unwinding only requires ATP binding, but not ATP hydrolysis (94). This suggests 
that binding of ATP with the protein changes the conformation of the helicase core 
and controls the affinity for the RNA. Therefore, it has been proposed that ATP 
hydrolysis is essential to recycle the enzyme by releasing the bound RNA (94).  
1.7.2 Mss116-mediated group II intron splicing mechanism   
Previous studies have shown that Mss116 can promote the efficient splicing 
of more than 13 different mitochondrial group I and group II introns of 
Saccharomyces cerevisiae in vivo (90,92). Inhibition of group I and group II intron 
splicing in yeast due to defects in the Mss116 gene can be suppressed by the 
overexpression of CYT19 (90). The DEAD-box protein CYT19 of Neurospora 
crassa is structurally very similar to Mss116 and is primarily involved in proper 
folding of mt group I introns. In addition to in vivo data, recent studies have shown 
that both Mss116 and CYT19 can promote the splicing of mt group I and group II 
introns in vitro under near-physiological conditions (89,92).        
 Biochemical studies have shown that CYT19 promotes the splicing of group 
I introns by resolving stable misfolded structures (kinetic traps) as an RNA 
chaperone (96). Since CYT19 can promote splicing of mt introns in Mss116 
knockout yeast, it has been predicted that both proteins may use an ATP-
dependent similar mechanism to facilitate splicing (90,92). However, experiments 
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conducted with Mss116 mutants that exhibit ATPase activity but are unable to 
unwind RNA duplexes indicated that unwinding is not strictly required for Mss116-
mediated intron splicing as suggested by previous studies (89). Therefore, these 
studies hypothesized that Mss116 is more likely to promote the splicing of the 
group II introns by stabilizing on-pathway folding intermediates (89,97). Folding 
studies of the group II intron ai5γ further support this hypothesis as no evidence 
was provided for the presence of any off-pathway kinetic traps (68,80). Although 
there are some experimental data to support both hypotheses, the exact 
mechanism of the Mss116-mediated group II intron splicing has not been 
elucidated yet.   
1.8 Nuclear pre-mRNA splicing 
 Pre-mRNA splicing is an essential step of eukaryotic gene expression by 
which non-coding intron sequences are removed from primary transcripts to form 
the mature mRNA. Mechanistically the pre-mRNA splicing reaction resembles 
group II intron splicing and it consists of two transesterification steps. However, in 
the nucleus, this process is catalyzed by a large ribonucleoprotein complex called 
the spliceosome, which is a dynamic assembly of five small nuclear RNAs 
(snRNAs) and a large number of proteins (98).  
  Introns are often present within eukaryotic protein coding genes and they 
consist of the 5’ splice site, the 3’ splice site and the branch site adenosine residue 
that are essential for splicing reaction (Fig. 1.7).  
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Figure 1.7 Eukaryotic nuclear pre-mRNA splicing reaction. The mechanism of 
pre-mRNA splicing reaction consists of two consecutive transesterification steps. 
The first step consists of a nucleophilic attack by the 2'-OH of the conserved 
branch-point adenosine on the scissile phosphate at the 5'-splice site. In the 
second step, the 3'-OH of the 5' exon attacks the phosphate bond at the 3'-splice 
site and ligates the two exons to form the mature mRNA. Adapted from reference 
99. 
 
31 
 
 
 
 The 5’ splice site contains an invariant GU sequence at the 5’ end of the 
intron and the 3’ splice site contains an invariant AG sequence at the 3’ end of the 
highly conserved consensus region of the intron as shown in Figure 1.7 (99). The 
branch site adenosine residue, which is essential for the pre-mRNA splicing 
reaction, is present upstream of the invariant AG sequence and the polypyrimidine 
tract that contains several pyrimidines (C and U).    
 Similar to the branching pathway of group II introns, the spliceosome-
catalyzed pre-mRNA splicing reaction (Fig. 1.7) consists of two sequential 
transesterification steps (99). In the first step, the 2’ hydroxyl of a highly conserved 
adenosine (the branch point) attacks the 5’ splice site resulting in a cleaved 5’ 
exon and an intron-3’exon RNA loop known as the lariat.  
 During the second step, the 3’ end of the 5’ exon attacks the 3’ splice site, 
cleaving the lariat intron and ligating the two exons together to form a mature 
mRNA that can be further processed for protein translation (99). Although the pre-
mRNA splicing reaction consists of two simple steps, the regulation of this process 
is critical to maintain proper cellular activities. Defects in this splicing process can 
lead to numerous diseases including cancer, Alzheimer’s and neurodegenerative 
disorders (100,101).  
1.9 The spliceosome    
 Five small nuclear RNAs – U1, U2, U4, U5, and U6 snRNAs assemble with 
more than 150 proteins to form small nuclear ribonucleoproteins (snRNPs) in the 
spliceosome (98,102). RNA-RNA and RNA-protein interactions between the 
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spliceosomal snRNPs as well as the pre-mRNA and the spliceosomal snRNPs are 
essential to regulate the splicing process (103).       
1.9.1 Assembly of the spliceosome    
 In order to perform eukaryotic pre-mRNA splicing, spliceosomal subunits 
must assemble with the pre-mRNA in a sequential manner (98). Assembly of the 
complex spliceosome has been extensively studied using several methods and it 
has been found that the pre-mRNA-directed spliceosome assembly pathway (Fig. 
1.8) is an ATP-dependent process consisting of several complexes (103). 
Furthermore, it has been shown that this process is highly conserved from yeast to 
humans (104).   
 During the spliceosome assembly, U1 snRNP first recognizes the 5’-splice 
site and forms the early (E) complex ATP-independently. Association of U2 snRNP 
with pre-mRNA bulges out the branch point adenosine that is required for the first 
step of splicing reaction and forms the pre-spliceosome or the complex A. Binding 
of the U4/U6.U5 tri-snRNPs with the pre-spliceosome forms the pre-catalytic 
spliceosome or the spliceosomal complex B. The pre-catalytic spliceosome 
undergoes several structural rearrangements and releases both U1 and U4 
snRNPs before it converts to the activated spliceosome or the complex B* (Fig. 
1.8). Both catalytic steps take place in the complex C that consists of U2, U6 and 
U5 snRNPs, which is known as the mature spliceosome. After the second catalytic 
step, the post-spliceosomal complex dissociates and releases the mature RNA for 
translation (103). 
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Figure 1.8 The spliceosome assembly pathway. Schematic representation of 
the spliceosome assembly pathway and the pre-mRNA splicing reaction. The 
nuclear pre-mRNA splicing reaction is catalyzed by the spliceosome. The 
assembly pathway of the spliceosome consists of stepwise integration of U1, U2, 
and U4/U6.U5 snRNPs. Reprinted from reference (103), Copyright (2009), with 
permission from Elsevier.     
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1.10 Spliceosomal U2-U6 snRNA complex    
 The active spliceosome, or the complex C, consists of U2, U5 and U6 
snRNP complexes. However, splicing studies conducted in vitro and in 
mammalian cell extracts have shown that a highly conserved loop of U5 snRNA is 
dispensable for the catalytic steps of pre-mRNA splicing (105,106). Therefore, 
despite the abundance of proteins in the spliceosome, it has been suggested that 
U2 and U6 snRNAs are the critical components for nuclear pre-mRNA splicing 
(11,13,107).  
 In addition to mechanistic and structural parallels between the spliceosome 
and self-splicing group II introns (108-110), there are several pieces of evidence, 
which support the catalytic ability of spliceosomal RNAs. First, U2 and U6 form 
direct base pairing interactions with the 5’ splice site and the branch point 
sequence during the first transesterification reaction. U2 binds the branch point 
directly (111), while the ACAGAG loop in U6 binds the 5’ splice site (112). Second, 
extensive base pairing interactions between U2 and U6 snRNA form a helical 
junction structure in the active spliceosome, thus bringing the 5’ splice site and the 
branch point into a close proximity. Third, Manley and Valadkhan have reported 
splicing related catalysis in vitro using a protein-free U2-U6 snRNA complex from 
humans, suggesting that proteins may not be directly involved in catalysis in the 
holo-spliceosome (11,13,107). Taken together, this evidence strongly suggests 
that U2 and U6 snRNAs (Fig. 1.9) form the catalytic core of the spliceosome and 
thus play an essential role during catalysis.  
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Figure 1.9 Structure of human and yeast U2-U6 snRNA complexes. a. 
Proposed structure of four-helix human U2-U6 snRNA complex. b. Proposed 
structure of three-helix human U2-U6 snRNA complex. c. Yeast U2-U6 snRNA 
complex. Top RNA strand is the U6 snRNA and bottom RNA strand is the U2 
snRNA. Conserved regions of both human and yeast U2-U6 complex are shown in 
red (ACAGAGA sequence, AGC triad and Mg2+ binding residue U-74 in human 
and U-80 in yeast). U6 ISL – U6 intramolecular stem loop. 
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1.10.1 Structure of human and yeast U2-U6 snRNA complex 
 Although it has been proposed that U2-U6 complex is essential for pre-
mRNA splicing, the structure of U2-U6 complex is still a matter of debate (Fig. 
1.9). Based on in vivo genetic studies, Guthrie and coworkers have proposed the 
three-helix structure for yeast U2-U6 complex (113). According to this structure, 
the highly conserved AGC triad in U6 base pairs with residues in U2 to form helix 
Ib. Mutational studies further indicated the formation of helix Ib as a requirement 
for both steps of splicing suggesting the previously proposed three-helix structure 
with helix Ib as a catalytically active conformation in yeast (114,115).  
 Similar to yeast U2-U6 complex, early mutational studies of human 
spliceosomal snRNAs suggests the three-helix structure for the U2-U6 complex in 
humans (116). However, later genetic studies conducted using a transient 
transfection assay with mutant U2-U6 snRNAs have indicated that residues 
involved in the formation of helix Ib in both U2 and U6 snRNAs participate in 
intramolecular rather than intermolecular base-paring (117). Therefore, this 
compensatory mutational study suggests that the human U2-U6 complex forms 
the four-helix structure without the previously proposed helix Ib (Fig. 1.9).  
 Interestingly, NMR studies support the four-helix structure for yeast protein-
free U2-U6 snRNA complex in vitro. According to NMR data, the AGC triad forms 
intramolecular base pairs within U6 snRNA and extends the U6 intramolecular 
stem-loop (U6 ISL) by forming the four-helix structure (108,117). Furthermore, 
these studies proposed that the four-helix structure brings the 5’ splice site close 
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to the U6 ISL to assist the first step of splicing. Although, it has been proposed that 
the two structures correspond to different spliceosomal activation states, 
conformational changes between these structures are not well understood.      
 Despite the fact that spliceosomal snRNAs are highly conserved among 
different organisms, significant differences have been observed between the U2-
U6 snRNA complex of humans and yeast (Fig. 1.9) (118). Human snRNAs contain 
numerous post-transcriptional modifications such as 2’-O-methyl groups and 
pseudouridines that are required for function (118,119). In addition, the stem I of 
human U2 snRNA contains C10-A23 and G11-U22 wobble base pairs instead of the 
tandem U-U wobble base pairs found in yeast (118). The observed structural 
variations between human and yeast U2-U6 complexes suggest that the function 
of these snRNAs in spliceosomal activation may have evolved somewhat 
differently in these species.  
 Recent NMR and UV melting studies by Butcher and coworkers have 
shown that the structures of the human and yeast stem-loop RNAs are nearly 
isosteric in vitro, but the post-transcriptional modifications within the human 
sequence increase its melting temperature by 18˚C, and thus, significantly 
increase its stability (118). The formation of helix Ib requires the melting of base 
pairs from U2 stem I. Consequently, the increased stability of modified U2 stem I 
potentially hinders the formation of helix Ib. Since helix Ib has been implicated with 
the activation of the spliceosome for the second transesterification reaction, these 
dissimilarities suggest that different activation mechanisms may take place.  
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1.11 Fluorescence-based detection of biomolecules  
 Detection of biomolecules and their interactions is necessary for the proper 
understanding of the highly complex biological processes. There are two main 
strategies for the detection of biomolecules in vivo and in vitro: label-free and 
label-based techniques. Label-free methods allow detecting biomolecules based 
on their properties without modifying the structure. However, low sensitivity and 
specificity are main disadvantages of this technique. In contrast to the label-free 
methods, labeling of biomolecules with fluorescent dyes or radioisotopes 
increases the sensitivity of the detection method (120). 
 Fluorescent-based techniques are one of the common label-based 
detection methods that enable characterization of the structure and function of 
biomolecules with high sensitivity (121). Based on unique properties of the 
fluorescent labels, these techniques are widely used in both in vivo cellular 
imaging and in vitro assays for direct detection of biomolecular interactions and 
structural studies.  
 Development of fast and sensitive detection techniques together with 
efficient fluorophore-labeling methods has increased the applicability of 
fluorescence in RNA science. Over the last few years, fluorescent-based detection 
techniques have been extensively used to study the complex RNA folding 
pathways and interactions between RNA-RNA and RNA-proteins in various 
biological systems.   
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1.11.1 Fluorescence theory   
 The emission of light from any molecule in the excited state is known as 
luminescence. Based on the properties of the excited state, luminescence can be 
divided into two types: fluorescence and phosphorescence. Phosphorescence 
occurs when a molecule emits the light from the triplet-excited state. In contrast, 
fluorescence occurs due to the emission of light from a molecule when it returns to 
the electronic ground state from the singlet-excited state.       
 Fluorescence is a common physical phenomenon that has fast emission 
rates (109 s-1) and exhibits lifetimes of ~10 ns. According to the Jablonski diagram 
(Fig. 1.10a), the absorption of light initiates the excitation of molecules from the 
ground state (S0) to the singlet-excited state (S1 or S2) containing a number of 
vibrational levels. Molecules in higher excited vibrational levels can be relaxed to 
the lowest vibrational levels through nonradiative processes such as vibrational 
relaxation (VR) and internal conversion (IC) within ~10-12 s. Fluorescence occurs 
when molecules emit light and reach the ground state from the lowest excited 
vibrational state. However, the loss of energy by means of intersystem crossing 
(ISC) between the singlet state (S) and the triplet state (T) shifts emission light into 
a higher wavelength than that of absorption light.       
1.11.2 Fluorescence Resonance Energy Transfer (FRET) 
 Fluorescence resonance energy transfer (FRET) is a distance-dependent, 
non-radiative energy transfer process between a donor (D) and an acceptor (A) 
fluorophore attached to a biomolecule (122). Upon excitation of the donor, the 
40 
 
 
 
energy is transferred to the acceptor and increases its emission intensity while 
decreasing the emission intensity of the donor fluorophore in an anti-correlated 
manner (Fig. 1.10b). Energy transfer arises from a dipole-dipole interaction 
between fluorophores. The efficiency of this process (EFRET) is given by, 
€ 
EFRET =
1
[1+ (R R0)6]                               
(1) 
R is the distance between two fluorophores and R0 is the Förster distance, the 
distance at which 50% energy transferring efficiency is observed (Fig. 1.10c). R0 is 
specific for a given pair of fluorophores and typically range between 3-8 nm (36). 
Förster distance can be calculated using following equation:  
€ 
R06 = 8.8 ×1023κ 2n−4QDJ  
            
(2) 
κ2 is a factor describing the orientation of the dipoles, n is the refracting index of 
the medium, QD is the quantum yield of donor in the absence of acceptor 
fluorophore and J is the spectral overlap integral.  
 The efficiency of this energy transfer is related to the inverse sixth power of 
the ratio of the distances between fluorophores. Therefore, FRET can act as a 
powerful molecular ruler that measures the intra- and inter-molecular motion of 
biomolecules in the 2-10 nanometer distance range (122,123). In addition to the 
distance between donor and acceptor fluorophores, FRET efficiency depends on 
several factors including the orientation of the donor and acceptor dipole moments 
and the spectral overlap between the emission spectrum of the donor and the 
excitation spectrum of the acceptor.  
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Figure 1.10 Jablonski energy diagram. a. Jablonski energy diagram that 
explains the general theory of the fluorescence. b. Jablonski energy diagram for 
FRET. c. Förster distance (R0) for Cy3 and Cy5. Vibrational levels of the ground 
state (S0) and the excited states (S1 & S2 singlet states and T1 triplet state) are 
shown in black lines. Excitation, fluorescence and phosphorescence processes 
are indicated using arrows. IC - internal conversion; ISC - intersystem crossing; 
λEX – excitation wavelength and λEM – emission wavelength. 
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1.11.3 Single-molecule fluorescence 
 Folding of RNA into an active conformation is a key requirement for proper 
functioning of RNA in cells. Due to the rugged nature of folding potential energy 
surfaces, RNA can follow complex kinetic pathways and adopt multiple 
intermediate conformations before reaching the native state. In order to 
understand the folding process, UV melting, Isothermal Titration Calorimetry (ITC), 
Circular Dichroism (CD) and chemical footprinting have been extensively used 
over the last few decades. However, all these traditional techniques deal with 
ensemble-averaged populations of a large number of molecules, which limits the 
amount of the information that can be obtained if multiple conformations are 
present in solution (36).  
 The emergence of single-molecule techniques has provided a huge 
advance in characterization of biomolecules, because it enables the direct 
observation of transient intermediates in isolated molecules, thereby resolving 
static and dynamic molecular heterogeneity and eliminating the requirement to 
synchronize all of the observed molecules to derive quantitative kinetic 
information. Therefore, single-molecule spectroscopy helps to deconvolute how 
complex biological systems function by revealing the kinetic steps otherwise 
hidden in ensemble-averaged bulk experiments.  
 Since the first single-molecule RNA folding study a decade ago, single-
molecule fluorescence has become a widely used technique to study the 
mechanisms of folding and catalysis in various RNA-based systems. The power of 
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single-molecule detection combined with the sensitivity of FRET has made single-
molecule FRET (smFRET) the most widely-used real-time detection technique to 
monitor structural dynamics, kinetics and thermodynamics of biopolymers. In order 
to achieve single-molecule sensitivity, it is critical to reduce all sources of 
background fluorescence (124). To this aim, two main techniques are often used: 
confocal and total internal reflection fluorescence (TIRF) microscopy. Both of 
these techniques reduce background fluorescence by limiting the detection 
volume. 
 In confocal microscopy, the out-of-focus light transmitted to the detector is 
reduced by a small aperture in the image plane of the microscope and detection is 
effectively limited to a small (femtoliter-size) volume, thus increasing the signal-to-
noise ratio by suppressing the background signal. Confocal microscopy helps 
detect freely diffusing molecules in solution (125). However, the short dwell time of 
these molecules in the detection volume is a primary limitation of this technique. In 
order to overcome this limitation, two main strategies have been developed during 
the past years: immobilization of the sample in agarose or polyacrylamide gels 
(126) and the surface immobilization of molecules by specific interactions, such as 
a biotin-streptavidin linkage (127). 
 In contrast to confocal microscopy, the prism-based TIRF microscopy aids 
in the detection of molecules by exciting with an evanescent wave generated by 
total internal reflection of a laser beam (Fig. 1.11). In order to totally reflect the 
laser beam, the angle of the incidence (θ) has to be larger than the critical angle 
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(θc). The evanescent wave generated at the slide-water interface by the incident 
light can excite molecules up to ~100-150 nm away from the slide surface (128). 
The emission of the donor and acceptor fluorophores can be collected through an 
inverted microscopic objective and transferred into a light-sealed box through a 
slit.  
 The first dichroic mirror (DM1) physically separates the donor and acceptor 
intensities and allows them to pass through the lenses (L1 and L2) to amplify the 
image. The second dichroic mirror (DM2) obtains the separated donor and 
acceptor signals through the mirrors (M1 and M2) and recombines the separated 
emission signals side-by-side to redirect into a high quantum yield CCD camera. 
The CCD camera amplifies the signals and transfers the digitalized frames to a 
computer for data analysis (Fig. 1.11).   
 Based on emission fluorescence intensities, the efficiency of FRET (EFRET) 
can be obtained by the equation below,  
€ 
EFRET =
IA
IA + ID      
(3)
 
where IA and ID are the acceptor and donor emission intensities, respectively. The 
reduction of the excitation volume to a thin sheet at the interface between the slide 
and the solution decreases the background signal and excessive photobleaching 
of molecules outside the detection volume. Furthermore, this technique facilitates 
the detection of a large number of molecules simultaneously in a wide observation 
field with the use of a CCD camera. 
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Figure 1.11 Setup of prism-based total internal reflection fluorescence (TIRF) 
single-molecule microscopy. Green line indicates the 532 nm excitation laser 
beam. The fluorescence emission intensity of the sample is collected by the 
objective and transferred to a light-sealed-box through a slit (s). Emission 
intensities of the donor (D) and acceptor (A) are separated using a dichroic mirror 
(DM) and directed to a CCD camera through the lenses (L) and a series of mirrors 
(M). Emission intensities are recorded by the CCD camera and the amplified 
signals are transferred to a computer to obtain corresponding FRET trajectories. Q 
– angle of incidence, QC – critical angle, IA – acceptor emission intensity and ID – 
donor emission intensity.   
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  These features increase the applicability of this technique by alleviating 
some of the disadvantages of confocal microscopy. However, the time resolution 
that can be obtained by current CCD cameras is still lower than that of the 
avalanche photodiodes (APD) and photomultipliers in confocal fluorescence 
microscopy (36,129).  
1.11.4 Fluorescence anisotropy  
 Fluorescence anisotropy is another widely used fluorescent-based 
technique that detects the rotational diffusion of a molecule based on the 
fluorescence polarization (130,131). Anisotropic measurements provide 
information about the size and the shape of molecules. Furthermore, this 
technique measures the binding interactions between two molecules; thereby 
permitting the determination of the binding constant or the dissociation constant for 
the specific interaction.  
 During fluorescence anisotropy assays, fluorophores are excited by vertical 
polarized light and emission intensities are measured in both vertical and 
horizontal directions through a polarizer (Fig. 1.12). Based on emission intensities, 
fluorescence anisotropy (r) can be calculated by, 
€ 
r = IV − IHIV + 2IH                                                       (4) 
where IV and IH are the fluorescent intensities in both vertical and horizontal 
directions, respectively.   
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Figure 1.12 Schematic diagram showing the principle of fluorescence 
anisotropy. Fluorophore labeled molecules in the sample cuvette are excited with 
vertically polarized light and the emission intensity of the vertically polarized 
fluorescence (Iv) and the horizontally polarized fluorescence (IH) are measured. 
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  According to the theory of fluorescence anisotropy, excitation polarized light 
selectively excites the molecules that have an absorption transition dipole parallel 
to the electric vector of excitation light. Based on the rotational freedom of 
molecules, this selective excitation results in a partially oriented population of 
polarized fluorescence emission. Therefore, binding of a large molecule with 
fluorophore-labeled substance decreases the rotational movements or the rate of 
tumbling and increases the value of anisotropy due to highly polarized emission 
light. In contrast, small molecules show fast rate of tumbling and depolarize the 
emitted light relative to the excitation plane decreasing the value of anisotropy.   
 Fluorescence anisotropy has a lower limit of detection in the sub-nanomolar 
range and allows monitoring the real-time interactions between biomolecules 
without using any hazardous materials. Therefore, anisotropy based detection 
methods have numerous advantages over most of the traditional techniques that 
are used to study biological interactions between proteins and nucleic acids. 
1.12 Specific aims 
 Group II introns and nuclear pre-mRNA splicing have been studied for 
many years using various experimental methods. However, thorough 
characterization of these splicing mechanisms is not feasible with most of these 
ensemble methods, which are unable to identify transient intermediates. The main 
goal of my dissertation was to combine fluorescence-based detection techniques 
with single-molecule approaches to characterize RNA splicing mechanisms in 
eukaryotes. To achieve this goal, the following specific aims were studied: 
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Specific aim 1: Characterization of group II intron folding pathway and the effect 
of Mss116 DEAD-box protein and ATP on the group II intron splicing mechanism. 
Group II introns can self-splice in vitro under high ionic strength conditions. In vivo, 
this process requires protein cofactors such as Mss116. The objective of this aim 
is to use single-molecule approaches to characterize group II intron splicing by 
monitoring protein-mediated RNA folding in real time. 
Specific aim 2: Characterization of structural dynamics of the U2-U6 snRNA 
complex that are essential for pre-mRNA splicing in humans. Several studies have 
suggested the primary contributors of spliceosome-catalyzed pre-mRNA splicing 
are the U2-U6 snRNAs. However, the structure and mechanism of the U2-U6 
snRNA complex involved in splicing remains debatable. To address this issue, we 
have employed a novel single-molecule approach to investigate the structural 
dynamics of the human U2-U6 snRNA complex in real time. 
Specific aim 3: Development of an RNA aptamer based affinity chromatographic 
method for purification of fluorophore-labeled proteins under non-denaturing 
conditions. Although it has been proven that fluorescence-based detection 
techniques are capable of elucidating the structure and mechanisms of complex 
biological systems in detail, the application of these techniques can be limited due 
to poor labeling efficiencies of biomolecules. In order to address this issue, we 
sought to develop an RNA aptamer-based affinity chromatographic method for 
purification of fluorophore-labeled proteins from unlabeled molecules under native 
conditions. 
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CHAPTER 2  
Materials and Experimental Methods 
2.1 Materials  
 Fluorophore-labeled (U6 and U6-1 RNA) and unlabeled RNA strands with 
or without modified bases (U2 and U6-2 RNA) as well as DNA oligonucleotides 
(Cy3-DNA, Cy5-DNA and Biotin-DNA) were purchased from The Howard Hughes 
Medical Institution Biopolymer/Keck Foundation Biotechnology Resource 
Laboratory (Yale University, New Haven, CT). D135-L14 group II intron RNA (638 
nt) and SRB-2 RNA (54 nt) were synthesized by in vitro transcription using T7 
RNA polymerase. SRB-2 template DNA was purchased from Sigma Genosys 
(Woodlands, Texas) and all NTPs (ATP, CTP, GTP & UTP) were purchased from 
Acros Organics (Morris Plains, New Jersey).  
 Tetramethylrhodamine-5-maleimide (TAMRAM) for protein labeling was 
purchased from AnaSpec, Inc., San Jose, CA and Cy5-NHS esters for RNA 
labeling was purchased from Amersham Biosciences. PEG-coated slides were 
made with 3-aminopropyltriethoxysilane (Vectabond, Vector Laboratories, Inc., 
Burlingame, CA), biotin polyethylene glycol succinimidyl carboxymethyl (BIO-PEG-
SCM, 3400/5000 MW) and methoxy polyethylene glycol succinimidyl 
carboxymethyl (m-PEG-SCM, 5000 MW, Laysan Bio. Inc., Arab, AL).  Mss116 was 
expressed and purified as explained in the methods section (37). 32P-labeled 
nucleotide triphosphates were obtained from MP Biomedicals, LLC. (Solon, OH).       
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 All chemicals used in these studies were purchased from either Sigma-
Aldrich or Fisher Scientific.    
2.2 Methods: Single-molecule analysis of Mss116-mediated group II 
intron folding 
2.2.1 Preparation of DNA, RNA and protein samples 
 The D135-L14 RNA (638 nt) was obtained by in vitro transcription of the 
HindIII digested pT7D135-L14 plasmid DNA with T7 RNA polymerase under 
standard conditions (68). Biotinylated DNA strand (5’-Biotin-TGC ATG CCT GCA 
GGT CGA CTC TA-3’), Cy3-DNA strand (5’-Cy3-ACC AAG AGC GTT ATT AAT-
5’), Cy5-DNA strand (5’-Cy5-ACG TAG TCC GAA ATA TAT-3’), wild type RNA 
substrate (17/7, 5’-CGU GGU GGG ACA UUU UCG AGC GGU-3’) and slower 
cleaving RNA substrate (17/7-dC, 5’-CGU GGU GGG ACA UUU UdC GAG CGG 
U-3’) were purchased from The Howard Hughes Medical Institution 
Biopolymer/Keck Foundation Biotechnology Resource Laboratory (Yale University, 
New Haven, CT). The 2’-OH positions were deprotected following the 
manufacturer’s protocol. All samples were purified by denaturing 18% PAGE and 
subsequent C8 reversed-phase HPLC, as described (37).  
 Mss116 was overexpressed in Rosetta 2 cells (Novagen) and grown at 
16°C overnight after induction. After purification of protein on a nickel column, it 
was cleaved with SUMO protease at 4°C overnight and purified using a gel 
filtration column. Untagged protein was concentrated by an Amicon ultra 
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concentrator and stored at -80°C. The activity of Mss116 was confirmed by in vitro 
splicing, ATPase and unwinding assays.  
2.2.2 Characterization of Mss116 activity 
 Activity of purified Mss116 was characterized by conducting in vitro splicing, 
unwinding and ATPase assays as explained below.  
Splicing assay - The body-labeled full-length ai5γ precursor RNA was incubated 
in 40 mM MOPS pH 7.5 at 90°C for 1 min followed by 3 min at 30°C. The RNA 
solution (1 nM final concentration) was added to a reaction mixture containing 20 
nM Mss116, 100 mM KCl, 40 mM MOPS pH 7.5 and 8 mM MgCl2, 5% glycerol, 2 
mM DTT and 2U/µL RNase inhibitor. After incubation for 10 min at 30°C, the 
splicing reaction was initiated with the addition of ATP (1 mM final concentration). 
The sample aliquots were removed at 0 and 120 min time points and detected 
using 5% native polyacrylamide gel.  
Unwinding assay - 250 nM Mss116 was pre-incubated with 0.1 nM end-labeled 
RNA duplex (12 bp) at 30°C for 10 min, and the unwinding reaction was initiated 
by the addition of ATP as described (89). The unwinding reaction was performed 
in 100 mM KCl, 40 mM MOPS pH 7.5, 4 mM MgCl2, 0.01% IGEPAL, 2 mM DTT, 
2U/µL RNase inhibitor and 4 mM ATP. Sample aliquots were removed at 0 and 30 
min time points and detected using 10% native PAGE.  
ATPase assay - 250 nM Mss116 protein was preincubated with or wthout 5 µM 
single-stranded RNA at 30°C for 10 min, and all reactions were initiated by the 
addition of a mixture of P-32 labeled and unlabeled ATP. ATPase assays were 
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performed according to standard protocol (132) in 100 mM KCl, 40 mM MOPS, pH 
7.5,  1 mM MgCl2, 2 mM DTT, 2U/µL RNase inhibitor and 1 mM ATP.   
2.2.3 Single-molecule FRET experiments 
 Protein-free single-molecule experiments were performed by heat-
annealing (90°C for 45 seconds) Cy3-DNA, Cy5-DNA, Biotin-DNA (10 µM each) 
and D135-L14 RNA (1 µM) in 100 mM KCl, 40 mM MOPS pH 7.5 and 0.5% 2-
mercaptoethanol. After the addition of 8 mM MgCl2, the reaction mixture was 
incubated at 30°C for 15-20 min. The fluorophore-labeled, biotinylated RNA/DNA 
complex was diluted to ~25 pM and bound to a streptavidin-coated quartz slide via 
a biotin-streptavidin linkage. Excess fluorophore-labeled and biotin-labeled DNA 
strands were removed from the slide by washing with reaction buffers. To 
minimize the non-specific binding of protein on the slide surface, all quartz slides 
were PEG-passivated using the BIO-PEG-SCM and the m-PEG-SCM.  
 In order to reduce photobleaching of fluorophores, an oxygen-scavenging 
system (OSS) consisting of 10% (w/v) glucose, 2% (v/v) 2-mercaptoethanol, 50 
µg/ml glucose oxidase and 10 µg/ml catalase was used in all experiments. The 
smFRET experiments with Mss116 were performed by introducing 25 nM Mss116 
with and without 1 mM ATP/AMPPNP in OSS solution as described (37). Similarly, 
smFRET experiments with the substrate (17/7 or 17/7-dC) were performed after 
addition of 25 nM substrate RNA into OSS solution containing 25 nM protein and 1 
mM ATP. All TIRF-based smFRET experiments were performed with 33 ms time 
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resolution at room temperature under different experimental conditions, as 
described (68).  
 FRET histograms from different experimental conditions were constructed 
by collecting ~100 single-molecule trajectories showing the transitions between 
different structural conformations. Since we cannot distinguish molecules in the 
unfolded state (U, FRET ~ 0) from those containing only a donor fluorophore 
(FRET = 0, due to photobleaching, for example), we did not include them in the 
FRET histograms.  
 Folding rate constants (k1, k-1, k2 and k-2) of the D135 ribozyme under 
different experimental conditions were obtained by analyzing FRET trajectories 
with a Hidden Markov Model (HMM) (133). First, FRET trajectories were fit using 
HMM and then transition density plots (TDP) were constructed to obtain folding 
rate constants as described (37). Threshold FRET values 0.27 and 0.51 were 
used to separate transitions among the three different FRET states. The effect of 
Mss116 without ATP was further determined in the presence of glucose and 
hexokinase. Incubation of the reaction mixture with glucose and hexokinase 
removes the trace amount of ATP associated with sample preparation.   
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2.3 Methods: Single-molecule studies of human spliceosomal U2-U6 
snRNAs  
2.3.1 RNA purification and labeling 
 5’-Cy3 labeled full length U6 RNA (5’-AUA CAG AGA AGA UUA GCA UGG 
CCC CdTG CGC AAG GAU GAC ACG CAA AUU CGU GAA GC-3’), U6-1 RNA 
(5’-Cy3-AUACAGAGAAGAUUAGCAUGGCCCCU-3’), U6-2 RNA (5’-AGG AUG 
ACA CGC AAA UUC GUG AAG C-3’ Biotin) and U2 RNA (5’ GCU UCU CGG 
CCU UUU GGC UAA GAU CAA GUG UAG UAU 3’) with or without modified 
bases (pseudouridine and 2’-O-methyl guanosines) were purchased from The 
Howard Hughes Medical Institution Biopolymer/Keck Foundation Biotechnology 
Resource Laboratory (Yale University, New Haven, CT). The 2’-OH deprotection 
reaction was performed as the manufacture’s protocol and the deprotected RNA 
was purified by denaturing 18% PAGE and subsequent C8 reversed-phase HPLC 
as described (68). The 3’ end of Cy3-HU6-1 and the internal dT of full length HU6 
RNA were labeled with Cy5 fluorophore and purified by reversed-phase HPLC.  
2.3.2 Steady-state FRET (ssFRET)  
 The ratio of U6-1:U6-2:U2 was chosen as 1:2:4 for complete hybridization 
of fluorophore labeled U6-1 with the other two RNA strands in 130 µl solution 
containing 100 mM NaCl, 50 mM TRIS-HCl pH 7.5 and 25 mM DTT. The samples 
were heat-annealed at 90°C for 1.5 min and incubated at room temperature for 15-
20 min. The ssFRET assay was performed by adding different concentrations of 
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Mg2+ (0-100 mM) at room temperature, and monitored using a Cary Eclipse 
fluorescence spectrometer. Cy3 was excited at 550 nm and emission of the donor 
and acceptor were recorded at 565 and 665 nm to obtain the FRET value using 
the equation, FRET = IA / (IA + ID). The subsequent FRET values were plotted 
against Mg2+ concentration and fitted to a binding equation as explained (134).   
€ 
FRET = FRET0 + (FRET0 − FRET∞)
[Mg2+]n
KMgn + [Mg2+]n
                        (5) 
where FRET0 and FRET∞ are the initial and final FRET efficiencies, respectively, 
KMg is the Mg2+ dissociation constant, and n is the cooperativity coefficient. 
2.3.3 Single-molecule FRET (smFRET) 
 Fluorophore-labeled U6 (1 µM) and U2 (5-10 µM) were heat-annealed 
(90°C for 45 s) in 100 mM NaCl, 50 mM TRIS-HCl pH 7.5 with different Mg2+ 
concentrations and incubated for 15-20 min at room temperature. In order to 
prevent U6 dimers, single-molecule experiments were performed in the presence 
of excess amount of U2 RNA (U6:U2 = 1:5 or 1:10) as suggested by previous 
studies (135) and the native polyacrylamide gel electrophoresis (native PAGE).   
 The fluorophore-labeled, biotinylated U2-U6 RNA complex was diluted to 
~25 pM and bound to a streptavidin-coated quartz slide via a biotin-streptavidin 
linkage. Unbound RNA strands were removed from the slide by washing with 
reaction buffers. In order to reduce photobleaching of fluorophores, an oxygen-
scavenging system consisting of 10% (w/v) glucose, 2% (v/v) 2-mercaptoethanol, 
50 µg/ml glucose oxidase and 10 µg/ml catalase was used in all experiments. 
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 FRET histograms at different [Mg2+] were constructed by collecting more 
than 100 molecules showing transitions between different states. Dwell times were 
calculated and plotted in dwell time histograms to obtain the folding rate constants 
as explained (134). Differences between free energy changes associated with the 
formation of the low FRET state for unmodified (U) and modified (M) U2-U6 
snRNA constructs were calculated as ΔΔG = ΔGM - ΔGU, where ΔG = -RT ln(K) 
and K = A0.2/A0.4 (A represents the area of a given FRET state in a FRET 
histogram). Error associated with ΔΔG was analyzed using the bootstrap method 
as described (136). The bootstrap method generates an auxiliary histogram by 
resampling each original data point in a histogram. The standard deviation of this 
auxiliary histogram provides a better estimation of the error associated with 
original data.   
2.4 Methods: An RNA Aptamer Based Purification System for 
Fluorophore Labeled Proteins 
2.4.1 RNA Synthesis and purification  
 The SRB-2 aptamer RNA (5’-GGA ACC UCG CUU CGG CGA UGA UGG 
AGA GGC GCA AGG UUA ACC GCC UCA GGU UCC-3’) was synthesized by in 
vitro transcription of the DNA template (5’-GGA ACC TGA GGC GGT TAA CCT 
TGC GCC TCT CCA TCA TCG CCG AAG CGA GGT TCC TAT AGT GAG TCG 
TAT TAC TG-3’). DNA was purchased from Sigma Genosys (Woodlands, Texas) 
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and all NTPs (ATP, CTP, GTP & UTP) were purchased from Acros Organics 
(Morris Plains, New Jersey).  
 In vitro transcription was carried out with 0.4 µM of the DNA template and 
0.4 µM of the T7 promoter (5’-CAG TAA TAC GAC TCA CTA TA-3’), transcription 
buffer (80 mM HEPES-KOH pH 7.5, 40 mM DTT and 2 mM Spermidine), 
polyethylene glycol (80 mg/ml), NTPs (4 mM each), Mg2+ (24 mM) and T7 RNA 
Polymerase (0.15 mg/ml) in 1 ml. The reaction mixture was incubated at 37°C for 
4 hrs and the transcribed products were purified by phenol-chloroform extraction, 
followed by ethanol precipitation. Transcripts were dissolved in 100 µl of 
formamide gel loading buffer and purified using 20% denaturing polyacrylamide, 8 
M urea gel electrophoresis followed by gel elution and ethanol precipitation. The 
resulting concentrations were determined by UV absorbance at 260 nm. 
 The transcription product was biotin labeled at the 3’ terminus in order to 
immobilize the SRB-2 aptamer on streptavidin-coated beads. The biotinylation 
occurs as a two-step reaction; the first of which converts the 2’ and 3’ hydroxyl 
groups of the 3’ terminal nucleotide to electrophillic aldehydes.  This is followed by 
the nucleophillic addition of biotinhydrazine (137). In the first step, 20 µL SRB-2 
aptamer (700 µM) were vacuum-dried and dissolved in 100 µL oxidation buffer (10 
mM Na-HEPES pH 7.5, 1 mM MgCl2). Then 14 µL 50 mM KIO4 were added and 
the reaction was incubated for 20 minutes at 0°C. The RNA was then purified by 
ethanol precipitation for nucleophillic addition of biotinhydrazine. The dried RNA 
was dissolved in 100 µL of 50 mM NaOAc, pH 5.0 and 1 µL saturated 
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biotinhydrazine solution was added to the reaction mixture. Saturated biotin 
solution was prepared by dissolving 11 mg biotinhydrazine in 250 µL distilled 
water. After incubating the reaction mixture overnight at 4°C, the biotinylated 
product was collected by ethanol precipitation and its concentration was measured 
by UV/Visible spectrophotometry. The biotinylation efficiency was estimated to be 
approximately 50% by HPLC.  
2.3.2 Fluorophore labeling of protein  
 Modified maltose binding protein containing a single cysteine residue was 
labeled with tetramethylrhodamine-5-maleimide (TAMRAM) by a maleimide-
cysteine reaction. The modified protein (2 nM) in 50 mM Tris-HCl pH 7.2 was 
incubated with 1 µl of TCEP (132 nM/µl) for 1 hour at room temperature. Protein 
was labeled by incubating overnight at 4°C with a 5-fold molar excess of TAMRAM 
(AnaSpec, Inc., San Jose, CA). Excess fluorophore was removed from the labeled 
protein by dialysis with selection buffer (100 mM KCl, 10 mM Na-HEPES, pH 7.4 
and 5 mM Mg2+) using a microcon YM-3 centrifugal filter as described by the 
manufacturer (Millipore Corporation). The concentrations of protein and 
tetramethylrhodamine (TAMRA) were calculated from their absorption at 280 and 
550 nm, respectively, as described (138).  
2.3.3 Fluorescence anisotropy measurements  
 Fluorescence anisotropy measurements were used to monitor the binding of 
TAMRA with SRB-2 aptamer in solution. TAMRA (AnaSpec, Inc., San Jose, CA) 
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was excited at 555 nm and all emissions were collected at 585 nm with 0.1 sec 
average time and 5 nm slit width (G factor = 2.1). Fluorescence anisotropy was 
calculated after measuring the emission intensities in vertical (IV) and horizontal (IH) 
directions. All anisotropic measurements were performed using a spectrofluorimeter 
(Cary Eclipse, Varian Inc.) in a solution containing 100 mM KCl, 10 mM Na-HEPES 
pH 7.4 and 250 nM TAMRA with varying concentration of SRB-2 aptamer, Mg2+ and 
EDTA. All measurements were taken in duplicate over a period of 3 minutes at 1 
minute intervals. Initial anisotropy (r0) of a TAMRA-only solution was low compared 
to that of a mixture of TAMRA and RNA due to the free rotation of the fluorophore 
molecules.  The binding of RNA molecules to TAMRA increases fluorescence 
anisotropy by restricting TAMRA’s free rotation. The resulting SRB-2 aptamer, Mg2+ 
and EDTA titrations were fit to the following equations, respectively: 
             
(6) 
         
(7) 
                                  (8) 
 
where r0 and rmax are the fluorescence anisotropies of free and SRB-2 bound 
TAMRA at saturation and [R] and [R.A] are the initial TAMRA and TAMRA- aptamer 
concentrations, respectively.    
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2.3.4 Affinity column protein purification assay  
 Streptavidin coated 6% crosslinked agarose beads (Pierce Biotechnology, 
Rockford, IL) solution (1 mL) was loaded into a 2 mL column and allowed to settle. 
The resulting column bed was then washed by passing 5 column volumes (5 x 
500µL) of binding buffer (100 mM KCl, 10 mM Na-HEPES, 5 mM MgCl2, pH 7.4) 
through the column. Then, 6.5 nmol of biotinylated SRB-2 aptamer were added to 
the column bed followed by 500 µL binding buffer. The biotinylated SRB-2 was 
allowed to bind with streptavidin-coated beads by incubating at room temperature 
for 30 minutes, before washing the column with 5 column volumes of binding buffer. 
Next, 0.4 nmol of the TAMRA-labeled maltose binding protein mixture was added to 
the column in one 200 µL aliquot and allowed to bind 30 minutes at room 
temperature. Excess protein, unlabeled protein and impurities were washed from 
the column using 5-8 column volumes of binding buffer. Each column volume was 
then analyzed by both fluorescence and UV-Visible spectrophotometric methods.  
 UV-Visible absorbance was measured to monitor the presence of MBP (A280) 
and TAMRA (A550) in buffer washings, and fluorescence spectra were recorded at 
λex = 550 nm to determine the presence of excess TAMRA (λem = 580 nm) labeled 
proteins. Labeled proteins were then eluted by adding one column volume elution 
buffer (5 mM EDTA, 100 mM KCl, 10 mM Na-HEPES pH 7.4). The chelation of 
Mg2+ was carried out for 10-15 minutes at room temperature. Complete elution of 
labeled proteins was achieved by passing 5 additional column volumes of elution 
buffer. Each column volume was then analyzed as described above. 
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CHAPTER 3  
Single-molecule Analysis of Mss116-mediated Group II Intron 
Folding  
(Adapted from Karunatilaka, K. S. et. al. Nature. 2010) 
3.1 Introduction 
 Group II introns are large multi-domain RNA molecules that can self-splice 
in vitro providing more evidence for the catalytic ability of RNA. The structure, 
splicing mechanism and folding pathway of this intron have been introduced in 
detail in the chapter 1.  
 The D135 ribozyme, the minimal active form derived from the group II intron 
ai5γ of Saccharomyces cerevisiae, consists of the necessary components for 
catalysis and is used as a model system to study group II intron folding and 
catalysis (Fig. 1.3). Previous studies have described the two-step folding pathway 
(U ↔ I ↔ N) for the D135 ribozyme (Fig. 1.5) which includes one obligatory 
intermediate under optimal in vitro splicing conditions (86). The unique folding 
pathway of this group II intron consists of an initial slow compaction step of domain 
I (D1), followed by rapid folding of the remaining domains onto the D1 scaffold to 
form the native state (N). 
 The unfolded state (U) is an extended form of the group II intron that forms 
in the presence of monovalent ions, thus it consists of secondary interactions, but 
lacks tertiary interactions. In the presence of both monovalent and divalent ions, 
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the U state folds slowly and forms the transient intermediate (I) with a collapsed 
D1 structure. This slow folding step (U ↔ I) is recognized as the rate limiting step 
of the group II intron folding pathway (80). Furthermore, it has been found that the 
initial collapse of domain 1 is mainly controlled by the region between κ – ζ in the 
center of D1 (61). This region is also involved in the binding of metal ions and the 
docking of the highly conserved D5 that forms the active site of the group II intron 
(61,139). The second step of folding (I ↔ N) is comparatively fast and has not 
been well characterized by traditional detection methods.  
 Previous studies have shown that the addition of monovalent ions 
decreases the hydrodynamic radius (R
H
) of the molecule from 146 to 81 Å due to 
the formation of an RNA conformation containing secondary interactions (86). 
Upon addition of divalent ions, the R
H
 further decreases to 61 Å indicating the 
formation of tertiary interactions (86). Single-molecule FRET (smFRET) has a 
unique ability to study the folding of molecules within 100 Å in real-time by 
detecting the transient intermediates that can be hidden in ensemble-averaged 
experiments. Therefore, the smFRET technique has been used to study the 
folding pathway of group II introns using D135 RNA as a model system (36).      
 Characterization of the fast folding step by TIRF-based smFRET 
experiments revealed three distinct structural conformations with a previously 
unidentified on-pathway folding intermediate (Fig. 3.1): I - extended intermediate 
state, F - folded intermediate state, and N - native state (68).  
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Figure 3.1 The folding pathway of the D135-L14 ribozyme. The folding pathway 
consists of four different structural conformations: U-unfolded state, I-extended 
intermediate state, F-folded intermediate state, and N-native state. k1, k-1, k2 and k-2 
are the rate constants for the structural transitions between different states. 
Adapted from reference (68) with permission from PNAS.  
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Furthermore, the observed fast folding rates between different states 
suggests these conformations are connected by small activation barriers. FRET 
time trajectories indicated that the native conformation occurs only transiently at 
20 mM or higher Mg2+ concentrations. However, the binding of the substrate with 
the intron stabilizes the high FRET conformation; thus, this structure likely acts as 
the active conformation of the ribozyme in vitro. Interestingly, it was found that 
increasing [Mg2+] leads to an increase in structural dynamics. The fraction of 
dynamic molecules versus [Mg2+] yields a dissociation constant that coincides with 
the values for bulk folding and cleavage (68). This result relates the D135 
structural dynamics with its catalytic activity and implies that domain motion may 
contribute to efficient catalytic activity of introns.  
 The splicing of group II introns in vivo is assisted by protein cofactors such 
as Mss116 (90). Mss116 is a DEAD-box protein belonging to the helicase 
superfamily 2 that has RNA-dependent ATPase and helicase activities. In addition 
to in vivo activity of Mss116, recent studies have shown its ability to facilitate the 
splicing of group II introns under near-physiological conditions (100 mM KCl, 40 
mM MOPS pH 7.5 and 8 mM MgCl2 at 30°C) in vitro (88,89).  
 Based on the properties of Mss116 DEAD-box protein, it has been 
proposed that Mss116 can promote group II intron splicing either by stabilizing on-
pathway intermediates or by disrupting misfolded structures (88,89,97). However, 
the exact mechanism of Mss116 activity on the group II intron splicing has not 
been elucidated yet. Studies conducted using other systems have shown that both 
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mechanisms are possible. For example, the LtrA protein encoded by a group IIA 
intron promotes self-splicing by binding the intron RNA (140). RNA chaperones, 
such as StpA, bind nonspecifically and unfold RNA to allow refolding into the 
active conformation (141,142).  
 Previous work has used the catalytic activity of group II introns to report on 
Mss116 function. However, to further understand how a DEAD-box protein 
facilitates RNA-folding, it is necessary to observe RNA folding directly. Therefore, 
we have characterized the effect of Mss116 on the folding dynamics of a 
fluorophore-labeled D135 ribozyme (D135-L14) using single-molecule 
fluorescence resonance energy transfer (68). Thereby we will be able to 
understand the mechanism of protein-mediated splicing in vivo. Furthermore, 
direct detection of interactions between Mss116 and its natural partner, ai5γ group 
II intron, will expand the existing knowledge of DEAD-box proteins in the RNA 
field.  
3.2 Experimental design 
 In order to perform single-molecule fluorescence experiments, it is essential 
to label D135 RNA with a fluorophore pair (donor and acceptor) that can satisfy all 
the requirements of FRET. Small RNA strands (<100 nts) can be easily 
fluorophore-labeled by attaching the fluorescent tags at terminal positions or 
internally during the solid-phase chemical RNA synthesis.  
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Figure 3.2 Secondary structure of the Sc. D135-L14 ribozyme. D135-L14 
ribozyme is (638 nt) derived from the group II intron Sc.ai5γ in the cox I gene of 
Saccharomyces cerevisiae (Sc.) D1 and D4 domains hybridize with DNA 
oligonucleotides labeled with Cy3 (green) and Cy5 (red) fluorophores, 
respectively. The 3’ end of the intron is elongated to bind with 5’-biotinylated 
complementary DNA strand for surface immobilization in smFRET experiments. 
The tertiary interactions are labeled by Greek letters. Adapted from reference (68) 
with permission from PNAS. 
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In contrast to small RNA constructs, the labeling of large RNA molecules 
(>100 nts) with fluorescent dyes is highly challenging, because long RNA 
molecules are difficult to chemically synthesize with a significant yield. Recent 
studies have found several methods for fluorophore labeling of large RNA 
molecules. The ligation-based labeling technique is one successful approach that 
can be applied for fluorophore labeling of large RNA molecules (143). However, 
the efficiency of this method is highly dependent on the length of the RNA 
construct.  
In addition to RNA ligation, hybridization of short fluorophore-labeled DNA 
or RNA oligonucleotides with single-stranded loop regions permits efficient 
labeling of large RNA molecules (144). This method promotes labeling of RNA 
molecules without forming covalent interactions. Because of its large size, D135 
RNA was fluorophore-labeled using the hybridization technique as previously 
described (68).  
In order to label D135 RNA with donor and acceptor fluorophores, two 
single-stranded loop regions have been introduced into two different locations (D1 
and D4) that are not absolutely essential for catalytic activity of group II introns 
(Fig. 3.2). Then, modified D135-L14 intron RNA was hybridized with DNA probes 
(Cy3-DNA and Cy5-DNA) as described (68). Furthermore, the 3’ end of D135 RNA 
was extended and hybridized with another DNA strand labeled with biotin (Biotin-
DNA) to immobilize the whole fluorophore-labeled, biotinylated complex on a 
quartz slide (Fig. 3.3).   
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Figure 3.3 Single-molecule detection by Total Internal Reflection (TIR) 
fluorescence microscopy. a. The secondary structure of fluorophore-labeled and 
biotinylated D135-L14 RNA. Fluorophore-labeled DNA oligonucleotides (Cy3 
Donor - green, Cy5 Acceptor - red) and biotin (yellow) labeled DNA oligonucleotide 
are shown in black. b. single-molecule setup showing the D135 RNA complex 
immobilized on PEG-passivated quart slide via a biotin-streptavidin linkage. The 
sample was excited by a laser beam at 532 nM and the emission was recorded by 
the CCD camera through an objective.    
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Folding dynamics of fluorophore-labeled group II introns in the presence 
and absence of Mss116 and ATP were detected by the TIRF-based single-
molecule fluorescence. To minimize non-specific binding of protein, the 
fluorophore-labeled and biotinylated D135-L14 ribozyme construct was 
immobilized on polymer (Polyethylene Glycol - PEG) passivated quarts slide via a 
biotin-streptavidin linkage (Fig. 3.3).   
3.3 Results  
3.3.1 Folding of group II introns alone requires high ionic strength 
 The folding pathway of the group II intron D135-L14 has been studied using 
single-molecule FRET in variable ionic conditions (68). Consistent with previous 
results, in high ionic strength conditions (8 mM MgCl2, 500 mM KCl and 80 mM 
MOPS pH 7.5 at 22˚C), the smFRET time trajectories of D135-L14 display 
repeated stochastic transitions among three distinct conformational states (Fig. 
3.4a): an extended intermediate (I, FRET ~ 0.1), a folded intermediate (F, FRET ~ 
0.4) and the native state (N, FRET ~ 0.6). Among all transitions, fewer than 2% of 
molecules show direct transitions between the extended intermediate and the 
native states, indicating that the folded intermediate state is an obligatory folding 
intermediate, as previously described (68).  
 In orthogonal studies employing gel-shift methodologies, the I, F and N 
states of D135 co-migrate as a single ‘compact’ species, and the functional native 
state can only be differentiated by the presence of catalytic activity (61,87). 
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Nonetheless, these two approaches are complementary because the gel shift 
assay can easily report on the transition between the unfolded state (U, FRET ~ 0) 
and the intermediate state (61,87,97), but the smFRET assay cannot because the 
U state is indistinguishable from species that are only labeled with the donor 
fluorophore (68,145).  
 In this study, the fluorophore-labeled D135-L14 was surface-immobilized 
via a biotin-streptavidin linkage on poly(ethylene glycol)-coated (PEG) quartz 
slides to reduce non-specific binding of RNA and proteins (146,147). However, the 
observed FRET histogram and traces are similar to those previously reported 
indicating that the PEG coating does not affect the behavior of D135-L14 alone 
(68).   
 In order to understand the behavior of group II introns in vivo, the folding 
dynamics of D135 RNA were monitored in vitro at the single-molecule level under 
near-physiological conditions (8 mM MgCl2, 100 mM KCl and 40 mM MOPS pH 
7.5 at 22°C). In contrast to the optimal splicing conditions described earlier, the 
D135-L14 ribozyme displays only one FRET distribution (FRET ~0.1) under near-
physiological conditions (Fig. 3.4b). According to the observed FRET trajectories, 
the vast majority of molecules reside in the extended intermediate state under 
these low ionic strength conditions (Fig. 3.4b).  
 Compared to RNA molecules in high ionic strength conditions, most of the 
observed molecules in low ionic strength were static and did not exhibit structural 
transitions between different conformations (compare Fig. 3.4a and b).  
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Figure 3.4 Effect of ionic strength on the folding dynamics of D135-L14 
ribozyme. a. Typical smFRET trajectory (left) showing the dynamics of a single 
D135-L14 ribozyme under high ionic strength conditions, and FRET histogram 
representing the distribution of FRET states of ~100 trajectories (right). The FRET 
trace indicates the presence of three different conformations: I (FRET~0.1), F 
(FRET~0.4) and N (FRET~0.6). Black line represents idealized HMM and arrows 
indicate rapid transient excursions to the N state. b. Typical FRET trajectory (left) 
showing the dynamics of a single D135-L14 ribozyme under near-physiological 
conditions, and histogram representing the distribution of FRET states from ~100 
trajectories (right).  
73 
 
 
 
The differences in the FRET distributions of the D135-L14 ribozyme in the 
two different ionic strengths confirm that under low ionic strength conditions the 
RNA folds primarily to the intermediate conformation and lacks structural 
dynamics, as previously observed (68,87).   
3.3.2 Mss116 facilitates group II intron folding in vitro  
 Since the splicing of ai5γ group II introns in vivo requires Mss116 as a 
protein cofactor, we characterized the effect of Mss116 on the folding of D135-L14 
under near-physiological conditions. The activity of our recombinant Mss116 was 
first confirmed by ATPase, unwinding and in vitro splicing assays (Fig. 3.5).   
Mss116 is a DEAD-box protein, which uses RNA-dependent ATP hydrolysis 
activity to perform its function. Therefore, the initial experiments were conducted in 
the presence of 1 mM ATP. The observed smFRET trajectories (Fig. 3.6a, b and 
c) and distributions of D135-L14 in the presence of Mss116 exhibit transitions 
between all three conformational states (I, F and N), in contrast to the smFRET 
distribution in the absence of protein. The appearance of the higher FRET states 
in the presence of the protein cofactor indicates that Mss116 facilitates folding of 
the RNA. In the presence of Mss116, ~30% of molecules reach the native state 
transiently or stably including a minor population of molecules (~9%) that remain 
static in the N state. To examine this effect more closely, we monitored the FRET 
ratio of a single D135-L14 ribozyme before and after addition of Mss116 and ATP 
(Fig. 3.6d).  
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Figure 3.5 ATPase, unwinding and splicing activity of the Mss116. a. ATPase 
activity of Mss116 in the presence and absence of RNA. NC represents the 
negative control in the absence of both protein and RNA. b. Unwinding of a 12 bp 
duplex with a 3’-overhang in the presence of Mss116, RNA and KCl. The figure 
shows the results obtained in the presence of Mss116 and ATP, without Mss116 
and without ATP at 0 and 30 min time points. DS - double-stranded and SS - 
single-stranded RNA. c. Splicing of ai5γ in the presence of Mss116 and ATP at 0 
and 120 min time points. Splicing was not observed in the absence of ATP or 
Mss116 even after 120 min. I-Lar – intron lariat, P – precursor, I-lin – linear and/or 
broken lariat intron, LE – ligated exons, 3E – 3′ exon and 5E – 5′ exon.  
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Before introduction of Mss116 and ATP, D135-L14 appears to be static in 
the extended intermediate state (FRET ~0.1). After addition of Mss116 and ATP 
(~15 s), transitions from the low FRET conformation to higher FRET conformations 
were observed, providing direct evidence of Mss116-mediated RNA folding.  
To evaluate the protein specificity of Mss116-induced folding, we examined 
the folding dynamics of D135-L14 in the presence of three different basic RNA-
binding proteins (Fig. 3.6e): HIV nucleocapsid - NC (148), Polypyrimidine tract 
binding – PTB (149) and Hfq proteins (150). The corresponding smFRET 
histograms show all three proteins can populate the folded intermediate to a lesser 
extent than Mss116, and none promotes folding into the native state. Among the 
molecules observed in the presence of each non-specific protein, more than 90% 
appear static in either the I or F state.  
Lowering the [Mg2+] to 1 mM yielded similar results, showing that Mss116 
can also help D135-L14 form F and N states under physiological conditions (Fig. 
3.7). However, we also observe a higher number of molecules in the 0 FRET 
state, suggesting that the number of molecules in the unfolded state is higher at 1 
mM [Mg2+]. Interestingly, at both 8 and 1 mM Mg2+, we find that the average FRET 
ratio of the extended intermediate increases to ~0.18 in the presence of Mss116 
(Table. 3.1), indicating that the protein induces a slight overall compaction of this 
conformer. 
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Figure 3.6 Mss116 promotes folding of group II introns at near-physiological 
conditions. a and b. FRET trajectories of a single D135-L14 ribozyme in the 
presence of Mss116 and ATP. Black lines represent idealized HMM and arrows 
indicate transient excursions to the native state. c. Histogram of the distribution of 
three structural conformations. d. FRET trajectory of the dynamic behavior of a 
single ribozyme upon addition of Mss116 and ATP at 15-20 seconds. e. FRET 
state distribution in the presence of the indicated non-specific RNA binding 
proteins. NC - nucleocapsid protein, PTB34 - Polypyrimidine tract binding protein, 
Hfq – host factor for RNA phage Q beta replication protein.  
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Unlike Mss116, none of these non-specific proteins affects the average 
FRET ratio of the extended intermediate, indicating that Mss116 may recognize 
this conformation more specifically (Table. 3.1). Taken together, these data show 
that the formation of the folded intermediate (F), which is the slow, rate-
determining step along the folding pathway (151), can be facilitated by a  diverse 
set of basic RNA binding proteins. However, the native state is only formed in the 
presence of Mss116 and ATP. Thus, Mss116 plays a specific role during the final, 
rapid stages of ai5γ folding.  
 
 
I – State F – State N- State 
Experimental 
Conditions Peak 
Center 
Area 
Peak 
Height 
Peak 
Center 
Area 
Peak 
Height 
Peak 
Center 
Area 
Peak 
Height 
500 mM KCl 0.12 0.70 0.121 0.37 0.15 0.024 0.61 0.03 0.003 
100 mM KCl 0.11 0.85 0.124 ND ND ND ND ND ND 
P Only 0.16 0.60 0.086 0.37 0.30 0.042 0.63 0.05 0.006 
P + ATP 0.16 0.40 0.067 0.37 0.40 0.048 0.62 0.13 0.015 
P + AMPPNP 0.17 0.60 0.078 0.37 0.30 0.034 0.62 0.05 0.006 
P + ATP+17/7 0.18 0.45 0.069 0.38 0.30 0.043 0.60 0.12 0.019 
P+ATP+17/7dC 0.18 0.50 0.073 0.38 0.20 0.041 0.62 0.16 0.021 
 
Table 3.1 Peak centers, areas and peak heights obtained by fitting the FRET 
histograms to Gaussians. All experiments in the presence of Mss116 (P) with or 
without ATP, AMPPNP and substrate RNA (17/7 or 17/7dC) were performed under 
near physiological conditions (8 mM MgCl2, 100 mM KCl and 40 mM MOPS pH 
7.5). ND – Not Detected. 
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Figure 3.7 Mss116 can promote the folding of group II introns at 
physiological conditions. a. FRET histogram showing the distribution of three 
structural conformations of D135-L14 in the presence of Mss116 and ATP in 
physiological conditions (1 mM MgCl2, 100 mM KCl and 40 mM MOPS pH 7.5). b. 
FRET histogram showing the distribution of three structural conformations of 
D135-L14 in the presence of Mss116 without ATP in physiological conditions.  
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In the cell, the group II intron also interacts with its substrate (Fig. 1.3), the 
exons, which are important components of the active site. The D135 ribozyme has 
an ability to actively cleave an exonic substrate under single- and multiple-turnover 
conditions. In a trans cleavage assay, D135 ribozymes can cleave a 17/7 exonic 
RNA substrate (24 nt) containing the last 17 nts of the 5' exon and the first 7 nts of 
the intron, comprising the 5' splice site using a hydrolytic reaction as shown in 
Figure 3.8a (68).  
Our previous single-molecule experiments have shown that the presence of 
an exon substrate (17/7 or 17/7-dC) stabilizes the native state of the group II 
introns (68). Indeed, under near-physiological conditions and in the presence of 
Mss116, ATP and the RNA substrate (17/7), all three folded states are populated 
(Fig. 3.8b). Additionally there is ~30% higher population in the native state (FRET 
~0.6) than that without RNA substrate (compare Fig 3.6 and 3.8).  
 Similar behavior was also observed with a slow-cleaving RNA substrate 
(17/7-dC, Fig. 3.8c), as expected (68). However, without Mss116 and ATP, the 
substrate RNA alone does not promote group II intron folding into the native state 
under near-physiological conditions. Overall, these substrate-based single-
molecule FRET data provide more evidence for the native state as a catalytically 
active conformation of group II introns. 
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Figure 3.8 Effect of substrate binding on the protein-mediated folding 
dynamics and native-state stabilization of group II introns. a. D135 ribozyme 
can cleave the 17/7 RNA substrate containing the last 17 nts of the 5' exon & the 
first 7 nts of the intron, comprising the 5' splice site. b. Histogram showing the 
FRET distribution of the fluorophore-labeled D135-L14 ribozyme in the presence 
of the slower cleaving substrate 17/7-dC. c. Histogram showing the FRET 
distribution of the D135-L14 ribozyme in the presence of the wild type substrate 
17/7. Both experiments were performed under near-physiological conditions (8 
mM MgCl2, 100 mM KCl and 40 mM MOPS pH 7.5) with 25 nM Mss116 and 1 mM 
ATP.  
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3.3.3 ATP hydrolysis by Mss116 is required to form the native state  
 In order to investigate the role of ATP on Mss116-mediated folding of D135, 
we monitored the folding dynamics under various conditions (Fig. 3.9). In the 
absence of ATP, the smFRET trajectories show transitions among all three 
conformations of the D135 ribozyme, as observed in the presence of ATP (Fig. 
3.9a). However, the population of the native state was ~2.5-fold lower in the 
absence of ATP, showing that ATP enhances formation of the native state. This 
small native state population may be due to traces of ATP that co-purify with 
Mss116 or D135-L14. However, control experiments in the presence of glucose 
and hexokinase, which remove traces of ATP from the protein solution, still show 
low levels of the native state population. These findings indicate that, while 
Mss116 facilitates folding to the native state in an ATP-dependent manner, the 
native state can also be inefficiently populated in the absence of ATP.     
 To examine the ATP dependence more carefully, we examined the folding 
dynamics of D135 with the non-hydrolysable ATP analog AMPPNP (Fig. 3.9b). In 
the presence of AMPPNP, we also observe the three structural conformations with 
a low population in the native state, as in the absence of ATP. Nonetheless, the 
population of molecules in the native state is ~2.5-fold lower than in the presence 
of ATP. In the absence of Mss116, however, ATP or AMPPNP alone are not 
sufficient to form the folded intermediate state or the native state. These data 
show that ATP binding and hydrolysis by Mss116 are important for the efficient 
formation of native D135 molecules, but hydrolysis is not strictly required.  
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Figure 3.9 Role of ATP in Mss116-mediated folding of group II introns. a. A 
typical FRET trace (left) and FRET histogram (right) showing the distribution of 
different conformations of the Mss116-mediated folding pathway in the presence 
of wild type Mss116 without ATP. b. A typical FRET trace (left) and FRET 
histogram (right) showing the distribution of different conformations in the 
presence of wild type Mss116 and the non-hydrolysable ATP analog, AMPPNP. 
Black lines represent idealized HMM and arrows indicate rapid transient 
excursions to the native state. c. Chemical structure of ATP and non-hydrolysable 
ATP analog - AMPPNP.   
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To further clarify the role of ATP binding and hydrolysis on group II intron 
folding, we studied the effect of two previously characterized mutations (K158A 
and K158R) in the Walker A box (Fig. 3.10), the most highly conserved region of 
the protein that is required for helicase activity of DExH/D proteins. According to 
structural characterization of these mutant protein constructs, the K158A mutant 
significantly binds with ATP but has greatly reduced ATP hydrolysis activity. In 
contrast, the K158R mutant is unable to bind and hydrolyze ATP under similar 
reaction conditions.  
 The corresponding smFRET histograms of both Mss116 mutant constructs 
clearly show the presence of the extended and the folded intermediates (FRET 
~0.2 and ~0.4, respectively, Fig. 3.10) with or without ATP. Further supporting our 
previously proposed hypothesis, these mutational data suggest that not only ATP 
binding, but also the hydrolysis of ATP is necessary to form the native 
conformation of group II introns. Rare transient excursions between the folded 
intermediate and the native state were observed with the K158A mutant in the 
presence of ATP, consistent with the previously reported low ATPase activity of 
this mutant.  
 In agreement with smFRET data obtained in the presence and absence of 
ATP and AMPPNP, these mutational studies show that efficient formation of the 
native state requires ATP hydrolysis but the folded intermediate state can be 
formed independent from ATP.  
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Figure 3.10 Effects of mutant Mss116 on group II intron folding dynamics. a. 
Schematic structure of Mss116 showing mutations (K158A and K158R) in the 
Walker A region. b. FRET histogram showing the distribution of different 
conformations in the presence of mutant K158A Mss116 with and without ATP. c. 
FRET histogram showing the distribution of different conformations in the 
presence of mutant K158R Mss116 with and without ATP. 
 
85 
 
 
 
3.3.4 Folding dynamics depend on Mss116 and ATP 
 To define the folding rate constants (k1, k-1, k2 and k-2), we analyzed the 
dynamic FRET trajectories (Fig. 3.11a) using a Hidden Markov Model – HMM (Fig. 
3.12, (133). Without Mss116 and under high ionic strength conditions, a large 
subpopulation (>75%) appears static in either the I or F states during the two-
minute timescale of our observation window (Fig. 3.11). Among the subpopulation 
of dynamic molecules (~24%), the observed folding rate constants between the 
extended and folded intermediates (k1 = 0.5 ± 0.3 s-1 and k-1 = 0.2 ± 0.1 s-1) agree 
closely with previous values (68).  
Under near-physiological conditions without Mss116, the dynamic 
subpopulation decreases to ≤5% (Fig. 3.11a). Therefore, folding rate constants 
could not be determined under these conditions. However, upon addition of 
Mss116 and ATP, the fraction of dynamic molecules increases to ~34%, and 
transitions to both F and N were observed (Fig. 3.11). The resulting folding rate 
constants (Table. 3.2) show that k1 and k-1 are comparable to the high ionic 
strength conditions (p>0.02), suggesting that Mss116 and Mg2+ stabilize these 
states similarly. However, in the presence of Mss116, k2 is ~3-fold higher and k-2 is 
~2-fold lower than in 100 mM Mg2+ (68), indicating that the protein stabilizes the 
native state more than Mg2+ ions (Table. 3.2).  
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Figure 3.11 Percentage of dynamic and static molecules and FRET traces 
showing the static behavior. a. Percentage of dynamic molecules under different 
reaction conditions (see figure legend). b. Percentage of static molecules in each 
conformational state and under different reaction conditions. c, d, and  e. 
Characteristic FRET trajectory of a static molecule in the extended intermediate 
state  (I ~ 0.1 FRET), in the folded intermediate state (F ~ 0.4 FRET) and in the 
native state (N ~ 0.6), respectively. Experiments were performed in either high 
ionic strength (8 mM MgCl2, 500 mM KCl and 80 mM MOPS pH 7.5) or near-
physiological conditions (8 mM MgCl2, 100 mM KCl and 40 mM MOPS pH 7.5) as 
mentioned. 
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 In the presence of Mss116 without ATP or with AMPPNP, ~30% of 
molecules exhibited dynamics. The resulting folding rate constants k1 and k-1 are 
comparable to those with ATP present (p>0.02). However, k-2 is 3 to 6-fold higher 
(p<0.02) than in the presence of ATP (Table. 3.2). This indicates that ATP 
hydrolysis, and not just binding, contributes to efficient formation of the native 
state. In the presence of Mss116 without ATP or with AMPPNP, the majority of 
molecules that dwell in F show transitions to I (~75%) rather than N (~25%). 
However, with both Mss116 and ATP, the percentage of F to I transitions 
decreases (58%) while the percentage of F to N transitions increases (42%). 
Therefore, ATP hydrolysis also increases the probability that F molecules sample 
N instead of I (Table 3.3).   
 
Experimental Conditions k1 (s-1) k-1 (s-1) k2 (s-1) k-2 (s-1) 
ATP- 0.5 ± 0.1 0.6 ± 0.2 0.2 ± 0.1 5.1 ± 1.3 
AMPPNP+ 0.6 ± 0.1 0.2 ± 0.1 0.3 ± 0.1 2.8 ± 0.7 Mss116 
ATP+ 0.3 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.9 ± 0.2 
 
Table 3.2 Single-molecule folding dynamics of D135-L14 ribozyme. k1, k-1, k2 
and k-2 represent the observed folding rate constants among three different 
conformations (I, F and N) as shown in figure 3.12. Folding rate constants under 
different experimental conditions were obtained by analyzing FRET traces with a 
Hidden Markov Model. All experiments were performed in 8 mM MgCl2, 100 mM 
KCl and 40 mM MOPS pH 7.5. The experiments with Mss116 were conducted in 
the presence or absence of ATP or AMPPNP as mentioned. Folding rate 
constants of D135 RNA in the presence of 100 mM Mg2+ under high salt 
conditions (500 mM KCl and 80 mM MOPS pH 7.5) without Mss116 and ATP are 
k2 = 0.07 s-1 and k-2 = 1.7 s-1. 
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Figure 3.12 Transition density plots (TDP) from HMM analysis. a. TDP 
showing transitions between different FRET states under high ionic strength 
conditions (8 mM MgCl2, 500 mM KCl and 80 mM MOPS pH 7.5) without Mss116 
and ATP. b. TDP showing transitions in the presence of Mss116 and ATP. c. TDP 
showing transitions in the presence of Mss116 without ATP. d. TDP showing 
transitions in the presence of Mss116 and AMPPNP. All experiments with Mss116 
with or without ATP and AMPPNP were performed in near-physiological conditions 
(8 mM MgCl2, 100 mM KCl and 40 mM MOPS pH 7.5). 
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Detailed analysis of static molecules in each state provides additional 
evidence for ATP-dependent Mss116 activity. In the presence of Mss116 without 
ATP, the fraction of static molecules in I decreases from 95% to 53%, and they 
begin to appear in both F and N (15% and 4%, respectively, Fig 3.11). In the 
presence of Mss116 with ATP, the fraction of static molecules in N increases 
significantly (2.5-fold, p = 0.02), while that in F does not change significantly (p = 
0.16). These data support an important role for ATP hydrolysis for efficient 
Mss116-induced folding of the intron ai5γ, as previously proposed (89,92). 
 
 
Percentage of Transitions Experimental 
Conditions 
F → I F → N 
Mss116 Only 73 27 
Mss116 + AMPPNP 74 26 
Mss116 + ATP 58 42 
 
 
 
Table 3.3 The percentage of transitions between conformational states. The 
percentage of transitions observed from the folded intermediate state (F) to either 
the extended intermediate state (I) or the native state (N) in the presence of 
Mss116 with or without ATP and AMPPNP. 
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3.4 Discussion  
 Based on previous biochemical and folding studies (80,87-89,92), it has 
been proposed that Mss116 can promote group II intron splicing by stabilizing on-
pathway intermediates and/or by disrupting off-pathway misfolded structures. 
Previous work has shown that ai5γ folds through a slow but smooth pathway 
devoid of kinetic traps (80,87), and an Mss116 mutant with a significant helicase 
defect still retains the ability to promote splicing (89,152). Other work supports a 
mechanism where Mss116 unwinds kinetic traps to promote splicing, even at low 
levels of helicase activity (88). Both models are primarily based on indirect studies 
of ai5γ splicing, thus, any putative role for Mss116 in RNA folding is purely 
hypothetical. To specifically examine the effect of Mss116 on ai5γ folding, we have 
employed a well-characterized smFRET assay that enables us to directly monitor 
the role of Mss116 and ATP on the intron folding.  
 Previous experiments showed that under near-physiological conditions, 
group II introns alone do not stably form the native state (87). Our data show they 
cannot even transiently sample the native state. The large subpopulation of static 
molecules in I (~95%) indicates a high activation barrier between I and F (Fig. 
3.12). The appearance of all three states in the presence of Mss116 shows that 
Mss116 can promote RNA folding by lowering the activation barriers between 
folded states, consistent with recent data (97,153).   
 We observe two distinct effects on folding. First, F state folding is promoted 
by Mss116 and other RNA-binding proteins even without ATP (Figs. 3.6 and 3.9). 
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The fact that diverse, basic RNA-binding proteins promote this stage of folding 
suggests that formation of the folded intermediate state is contingent on 
electrostatic stabilization or annealing. The lack of ATP dependence also shows 
that mechanical events such as translocation or duplex unwinding are not involved 
in the obligate early steps of ai5γ folding. Although diverse proteins stimulate the 
I→F transition, only Mss116 increases the FRET ratio of I (~0.12 to ~0.18), 
indicating a specific interaction with the extended intermediate (Table. 3.1). The 
higher FRET value suggests a slightly more collapsed I state in the presence of 
Mss116, and that this protein is ideally suited to folding of ai5γ.  Second, Mss116 
promotes folding to the native state through a mechanism involving ATP 
hydrolysis. Without ATP or with AMPPNP, only a small fraction of molecules reach 
the native state, indicating that ATP hydrolysis contributes to the function of 
Mss116 specifically during native state formation.  
 Several possible models explain the function of Mss116 during native state 
formation. In a stabilization model, Mss116 may bind and stabilize the κ−ζ region, 
a substructure of domain 1 that must form before the intron can productively fold 
(61). This same substructure contains a binding site for the catalytic domain 5, 
which docks late in the assembly pathway (87). If Mss116 stimulates folding by 
stabilizing the κ−ζ element, it will then be required to dissociate before D5 can 
stably dock within the core. Thus, ATP hydrolysis may stimulate a conformational 
change in Mss116 that allows the protein to be released during the last stage of 
the folding process, consistent with previously published findings indicating that 
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ATP hydrolysis is required for Mss116 turnover and dissociation from RNA 
(94,152). The formation of a small fraction of the native population in the absence 
of ATP is consistent with this model, as Mss116 is likely to have a finite off-rate. In 
vivo, efficient recycling of Mss116 may be necessary to maintain a pool of active 
Mss116 enzymes, and may allow the cell to overcome non-functional binding 
events while preventing inhibition of properly folded RNAs (152).  
However, other models, such as unwinding during the final transition from 
the folded intermediate to the native state, also remain possible. According to this 
model, the protein would first facilitate the slow, early stages of folding (including 
D1 collapse) through electrostatic interactions, but formation of the final native 
state may be impeded by one or more small misfolded structures. To form the 
correctly folded structure, the protein would resolve the small misfolded structures 
through strand exchange or unwinding by local strand separation. This ATP-
dependant remodeling event would provide an opportunity for the native contacts 
to form. Although we do not have direct evidence for the presence of misfolded 
structures, we have previously shown that I, F and N are likely heterogeneous 
(68). Thus, it is possible that misfolded intermediates with FRET ratios similar to 
on-pathway intermediates are present but not readily distinguishable. However, 
recent in vivo experiments show that the ability of Mss116 to hydrolyze ATP 
correlates with function even with different degrees of helicase activity, in 
agreement with a recycling function for ATPase activity (152). Helicase activity 
may play additional roles in the presence of long exons (154). 
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Figure 3.13 Mss116-mediated group II intron folding pathway. a. D135-L14 
minimal folding pathway: the unfolded state (U), the extended-intermediate state 
(I), the folded-intermediate state (F) and the native state (N). Folding rate 
constants of I, F and N are k1, k-1, k2 and k-2 respectively. b. Hypothetical free 
energy diagram for folding of the D135-L14 based on pre-steady state data and 
previous work (68,97). In the absence of Mss116 and ATP (black), extended 
intermediate state is the most stable conformation of the ribozyme. Mss116 alone 
(purple), results in formation of the folded intermediate state. Addition of both 
Mss116 and ATP with and without trans exon-17/7 RNA (red and green, 
respectively) enhances native state formation (68). Cis exons (gray) further 
stabilize the native state of group II introns (97).   
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Taken together, we observe multiple roles for Mss116 in the folding 
pathway of ai5γ and we propose that Mss116 mediates group II intron folding by 
stabilizing on-pathway intermediates and transition states from the unfolded state 
to the folded states. We also observe that efficient transition from the folded 
intermediate to the native state requires ATP hydrolysis, possibly for Mss116 
release and recycling (Fig. 3.13). The substrate further stabilizes the native state, 
raising the interesting possibility that in vivo and in the presence of all the group II 
intron domains and Mss116, the native state becomes the most stable 
conformation. 
3.5 Conclusions 
 DEAD-box proteins are highly conserved across all domains of life, and 
they are involved in nearly all aspects of RNA metabolism; however, the 
mechanism of many of these proteins remains unclear. The discovery that Mss116 
facilitates splicing of all group I and II introns in yeast mitochondria (90) has 
provided a rare opportunity to study how DEAD-box proteins might promote folding 
of their native RNA substrates. Therefore, studies of the Sc.ai5γ group II intron 
derivative and its natural cofactor, Mss116, provide key insights into both protein-
mediated RNA folding and catalysis. 
 Previous biochemical and folding studies (80,87-89,92) have proposed that 
Mss116 can promote group II intron splicing by stabilizing on-pathway 
intermediates and/or by disrupting misfolded structures. However, the exact 
mechanism of protein-mediated splicing is still under debate. Group II intron ai5γ 
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has been shown to fold through a slow but smooth pathway devoid of kinetic traps 
(80,87). Furthermore, an Mss116 mutant with a significant helicase defect still 
retains the ability to promote group II intron splicing (88,89,155). Based on these 
observations, it has been suggested that Mss116 uses a stabilization mechanism. 
In contrast, some evidence supports a mechanism by which Mss116 unwinds 
kinetic traps to promote splicing, even at low levels of helicase activity (88,89). 
Both mechanisms, however, are primarily based on indirect studies of ai5γ 
splicing, and thus any putative role for Mss116 in RNA folding is purely 
hypothetical. As a result, the effect of Mss116 on ai5γ folding has been 
characterized using a single-molecule fluorescence assay that enables the direct 
observation of the influence of Mss116 and ATP on the group II intron folding.  
 According to the smFRET data, group II introns cannot reach to the 
catalytically active native state alone under near-physiological conditions due to 
large activation barriers between states. However, the DEAD-box protein Mss116 
or non-specific basic RNA binding proteins can lower the activation barriers and 
promote the folding of intron RNA to the higher FRET conformations. Although the 
transitions from the extended intermediate state to the folded intermediate state 
are independent on ATP hydrolysis, the binding and hydrolysis of ATP is required 
for efficient formation of the native state under these conditions. Based on 
previous studies that have shown DEAD-box proteins need ATP hydrolysis to 
release RNA from proteins (94) and our experimental observation that early rapid 
folding steps are independent from ATP hydrolysis, we proposed that ATP 
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hydrolysis occurs in the final steps and facilitates the formation of the folded native 
state by recycling the Mss116. Furthermore, in the presence of Mss116 and ATP, 
it has been shown that the RNA substrate containing exons can enhance the 
formation of the native state providing additional evidence for the native state as 
the catalytically active conformation.    
 In summary, we observe that Mss116 has multiple roles in the folding 
pathway of ai5γ and we propose that Mss116 mediates group II intron folding by 
stabilizing on-pathway intermediates upon transition from the unfolded state to the 
folded state. However, we also observe that the transition from the folded 
intermediate state to the native state requires ATP hydrolysis as illustrated by our 
free-energy diagram (Fig. 3.13). According to this scheme, unfolded group II intron 
ribozymes (U) slowly collapse to the extended intermediate state (I) under near 
physiological conditions, as previously observed (87). This transition is so slow 
that we do not expect to observe it in our experiments. The extended intermediate 
can interact with Mss116 to further compact this state. Next, Mss116 (or other 
proteins) induce the formation of the folded intermediate (F). Finally, the native 
state is stably formed once ATP is hydrolyzed, possibly upon Mss116 release. Our 
data also show that the presence of substrate further stabilizes the native state, 
raising the interesting possibility that in vivo and in the presence of all the group II 
intron domains and Mss116, the native state becomes the most stable 
conformation. 
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CHAPTER 4  
Single-molecule Studies of Human Spliceosomal U2-U6 snRNAs 
4.1 Introduction 
 Spliceosome-catalyzed nuclear pre-mRNA splicing is an essential process 
in eukaryotic gene expression (Fig. 1.1). The assembly pathway of the 
spliceosome and the mechanism of pre-mRNA splicing have been introduced in 
previous chapters (98,99). Although the spliceosome consists of five snRNAs and 
more than 150 proteins (98,102), it has been shown that the active spliceosome 
consists of only U2, U5 and U6 snRNPs. Additionally, several studies have 
proposed the U2-U6 snRNA complex is the catalytic core of the spliceosome 
(11,13,107).       
 Spliceosomal U2 and U6 snRNAs play an important role in pre-mRNA 
splicing in all eukaryotes. The structure and the catalytic ability of this U2-U6 
snRNA complex have been discussed in detail in Chapter 1 (108,113-118). In 
summary, two main structures have been proposed for both human and yeast U2-
U6 snRNA complexes (Fig. 1.9). In vivo genetic studies support the three-helix 
structure containing helix Ib for yeast U2-U6 snRNA complex (113,114). It has also 
been postulated that the three-helix structure is required for both steps of pre-
mRNA splicing in yeast. In contrast, NMR studies support the four-helix structure 
for the yeast protein-free U2-U6 complex in vitro (108). Although it has been 
proposed that the U2-U6 complex can adopt two conformations that reflect 
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different spliceosomal activation states, there was no direct experimental evidence 
to support that hypothesis.  
 In order to understand the structural dynamics of U2-U6 spliceosomal 
RNAs, protein-free yeast U2-U6 snRNA complexes were monitored using single-
molecule fluorescence (134). Structural dynamics of the wild type and mutant 
yeast U2-U6 complex, which have mutations in highly conserved regions, show 
the presence of at least three distinct conformations in dynamic equilibrium: the 
low FRET state (~0.2), the mid FRET state (~0.4) and the high FRET state (~0.6). 
As a result, the single-molecule data led to the hypothesis of a minimal two-step 
folding pathway for yeast U2-U6 complex with an obligatory folding intermediate 
(134). Furthermore, single-molecule data suggested Mg2+ can facilitate the 
conformational changes; notably, the first step strongly depended on the 
concentration of magnesium ions.  
 Based on the single-molecule studies and previous experimental data, the 
high FRET state was assigned the four-helix structure proposed by the NMR data, 
the low FRET state was assigned the three-helix structure proposed by the genetic 
data and the mid FRET state was assigned the intermediate conformation. Mutant 
U2-U6 snRNA complexes with mutations in highly conserved residues 
corresponding to the formation of helix Ib further confirmed that the low FRET 
state was the three-helix structure with helix Ib (134). Taken together, single-
molecule studies of yeast U2-U6 spliceosomal RNAs indicate that the U2-U6 
complex can adopt both previously proposed structures in vitro. 
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 Similar to the previously proposed yeast U2-U6 three-helix structure, early 
in vivo genetic studies suggest that human U2-U6 spliceosomal RNAs also form 
the three-helix structure with helix Ib (116). However, later studies conducted with 
mutant U2-U6 constructs have proposed that helix Ib residues in both U2 and U6 
snRNAs participate in intramolecular rather than intermolecular base paring (117). 
As a result, the catalytic structure of the human U2-U6 snRNA complex is still 
uncertain.     
 The sequences of spliceosomal snRNAs are highly conserved among 
different organisms. However, significant differences exist between human and 
yeast U2-U6 snRNAs suggesting these two organisms may have different 
activation mechanisms (Figs. 1.9 and 4.1). There are two major differences 
between human and yeast U2-U6 snRNA complexes (118).  
1) Human snRNAs contain numerous functional post-transcriptional 
modifications such as 2’-O-methyl groups and pseudouridines (118).  
2) Stem I of human U2 snRNA contains C10-A23 and G11-U22 wobble base 
pairs instead of the tandem U-U wobble base pairs found in yeast (118).     
The majority of these conserved post-transcriptional modifications are clustered in 
functionally important regions of snRNAs and perform either RNA-dependent or 
protein-dependent functions. Out of five snRNAs, U2 snRNA is highly post-
transcriptionally modified and contains ten 2′-O-methylated residues and thirteen 
pseudouridines. 
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Figure 4.1 Structures of modified residues and U2 stem I of yeast and 
humans. a. Chemical structures of the modified residues in human spliceosomal 
snRNAs. b. Structural differences between U2 stem I of yeast and human 
spliceosomal snRNAs.       
 
101 
 
 
 
Interestingly, recent NMR and UV melting studies by Butcher and 
coworkers have shown that the structures of the human and yeast stem-loop 
RNAs are nearly isosteric in vitro, but the post-transcriptional modifications (Fig. 
4.1) within the human sequence increase its melting temperature by 18˚C, and 
thus, significantly increase its stability (118). Since stem I plays an important role 
in the formation of helix Ib, the higher stability of human U2 stem I may affect the 
formation of helix Ib in humans. Previous studies have proposed that the formation 
of helix Ib is essential for the activation of the spliceosome for the second 
transesterification reaction in yeast. Therefore, dissimilarities between these two 
species suggest that different spliceosomal activation mechanisms are possible 
during the splicing reaction. 
 In addition to structural differences between human and yeast spliceosomal 
RNAs, it has been shown that protein-free human U2-U6 snRNA complexes can 
catalyze a splicing related reaction in vitro (11,13,107). Furthermore, consistent 
with the structural complexity, previous studies have found that human 
spliceosomal snRNAs associate with more proteins than yeast snRNAs.        
 The primary objective of this study is to understand and compare the 
structural dynamics of human and yeast U2-U6 spliceosomal snRNAs. In order to 
achieve that goal, Mg2+-dependent structural dynamics were monitored at the 
single-molecule level. Furthermore, to investigate the roles of highly stable U2 
stem I modifications on structural dynamics, single-molecule fluorescence was 
used to directly observe and quantify the effects of these modifications (2’-O-
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methyl groups and pseudouridines) on the stability and dynamics of the human 
U2-U6 complex.  
4.2 Experimental design 
 To reveal structural dynamics of human spliceosomal snRNAs, a 
fluorophore-labeled U2-U6 snRNA complex was studied using single-molecule 
fluorescence. Based on the proposed structure of the U2-U6 complex, the FRET 
donor (Cy3) was incorporated at the 5’ end of U6 and the U6 ISL was internally 
labeled with the FRET acceptor (Cy5). The 3’ end of the U6 strand was labeled 
with biotin to immobilize the fluorophore-labeled U2-U6 construct on a slide (Fig. 
4.2). The fluorophore-labeled and biotinylated U2-U6 complex was immobilized on 
a quartz slide via a biotin-streptavidin linkage and the folding dynamics of the U2-
U6 snRNA complex were directly monitored using TIRF-based single-molecule 
microscopy. 
Since the labeling efficiency of the full length U6 snRNA in the two-strand 
U2-U6 complex was low, a three-strand U2-U6 complex was used to characterize 
the folding dynamics using steady-state fluorescence. To enhance the labeling 
efficiency, U6 snRNA has divided into two strands (U6-1 and U6-2). Similar to the 
yeast U2-U6 complex, the FRET donor (Cy3) was incorporated at the 5’ end of 
U6-1, and the FRET acceptor (Cy5) was attached to the 3’ end of U6-1. 
Furthermore, the 3’ end of U6-2 was biotinylated as previously described (Fig. 
4.2). 
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Figure 4.2 Human U2-U6 snRNA complexs. a. Two-strand (U6 and U2) human 
U2-U6 snRNA complex. The 5’ end of the U6 snRNA was labeled with the FRET 
donor (Cy3) and the U6 snRNA was internally labeled with the FRET acceptor 
(Cy5). Biotin was attached to the 3’ end of the U6 snRNA for surface 
immobilization.  b. Three-strand (U6-1, U6-2 and U2) human U2-U6 snRNA 
complex. The 5’ end of the U6-1 was labeled with the FRET donor (Cy3) and the 
3’ end of the U6-1 was labeled with the FRET acceptor (Cy5). Biotin was attached 
to the 3’ end of the U6-2 for surface immobilization. Highly conserved regions (the 
ACAGAGA sequence, the AGC triad and a magnesium binding residue U-74) are 
shown in red.   
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4.3 Results  
4.3.1 Mg2+-dependent structural dynamics by steady-state FRET 
 Magnesium ions play an essential role during the pre-mRNA splicing 
reaction by facilitating RNA folding and catalysis. Mg2+-dependent folding 
dynamics of the three-strand U2-U6 complex were first characterized using the 
steady-state FRET (ssFRET, Fig. 4.3) in standard buffer conditions (50 mM TRIS-
HCl pH 7.5 and 100 mM NaCl). Steady-state FRET is a very sensitive technique to 
monitor global structural changes of small RNAs. In the absence of Mg2+, the 
emission intensity of donor was lower than that of the acceptor providing the high 
FRET state (FRET ~0.5). As suggested for the yeast U2-U6 complex, the high 
FRET state was assigned to the four-helix structure containing the highly 
conserved ACAGAGA loop and the U6 internal stem-loop (ISL) in close proximity.  
 Upon addition of 40 mM Mg2+, the emission intensity of the donor increased 
substantially while decreasing the acceptor intensity providing evidence for Mg2+ 
induced conformational change (Fig. 4.3). The observed low FRET state (FRET ~ 
0.2) was assigned to the three-helix structure with helix 1b, where the ACAGAGA 
loop was separated from the U6 ISL. The Mg2+ dependence of the U2-U6 
conformational change was determined by plotting the FRET efficiency as a 
function of Mg2+ concentration (Fig. 4.3). The resulting isothermal titration was 
fitted to a Mg2+ binding equation (Eq. 5, page 56).      
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Figure 4.3 Steady-state fluorescence. a. The emission spectra of fluorophore-
labeled U2-U6 snRNA complex at 0 mM (red) and 40 mM (blue) Mg2+. b. Mg2+ 
dependence of the FRET efficiency of fluorophore-labeled modified and 
unmodified human U2-U6 complexes. Circles represent the unmodified U2-U6 
complex data and squares represent the modified U2-U6 complex data. The black 
lines are fittings of steady-state FRET data to the binding equation (Eq. 5, page 
56).      
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 The observed Mg2+ dissociation constant of human U2-U6 complex, KMg = 
2.1 ± 0.4 mM, is consistent with yeast spliceosomal snRNAs (KMg = 3.3 ± 0.7 mM). 
Those data suggest the metal ions that have been found to be important factors in 
the activation of the spliceosome may contribute to the conformational changes of 
the U2-U6 complex.  
4.3.2 Mg2+-dependent structural dynamics by single-molecule FRET 
 Single-molecule fluorescence has an ability to dissect RNA folding 
pathways by revealing transient folding intermediates that can be hidden in bulk 
experiments. Therefore, single-molecule fluorescence was applied to the two-
strand human U2-U6 complex to elucidate the Mg2+-dependent folding dynamics 
in detail.  
The effect of Mg2+ concentration on the structural dynamics of individual 
U2-U6 snRNA complexes was measured at several Mg2+ concentrations ranging 
from 10 to 40 mM (Fig. 4.4). The resulting smFRET trajectories at different Mg2+ 
concentrations clearly identified the existence of distinct FRET efficiencies 
corresponding to three different conformational states in dynamic equilibrium as 
previously observed in the yeast U2-U6 snRNA complex (134): the low FRET state 
(FRET ~ 0.2), the mid FRET state (FRET ~ 0.4) and the high FRET state (FRET ~ 
0.6). At high Mg2+ concentration (40 mM), the majority of molecules populated the 
0.2 FRET state. However, when we decreased the Mg2+ concentration to 10 mM, 
the population of the low FRET state conformation decreased while the population 
of higher FRET states increased (Fig. 4.4a and b). 
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Figure 4.4 Mg2+-dependent structural dynamics of the human U2-U6 snRNA 
complex. a. A typical FRET trajectory and FRET histogram of human U2-U6 
complex in 10 mM Mg2+. b. A typical FRET trajectory and FRET histogram of 
human U2-U6 complex in 40 mM Mg2+. c. Structure of the human U2-U6 snRNA 
complex containing flipped bases (blue) in the U2 stem I (4-fold mutant). The 
FRET donor – Cy3 (green), the FRET acceptor – Cy5 (red) and the biotin (grey) 
are shown using circles. d. FRET histogram of the human 4-fold mutant U2-U6 
complex in 10 mM Mg2+.  
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Based on smFRET data and sequence similarities between human and 
yeast U2-U6 snRNAs, we propose a two-step folding pathway for the human U2-
U6 snRNAs similar to yeast (Fig. 4.5a). We assigned the high FRET state (~0.6) to 
the four-helix structure, the low FRET state (~0.2) to the three-helix structure and 
the mid FRET state (~0.4) as an obligatory folding intermediate. In order to confirm 
the low FRET state corresponds to the three-helix structure with helix Ib, folding 
dynamics were monitored using a four-fold mutant that prevents helix Ib formation. 
Four bases in the U2 stem I were flipped to prevent base pairing of residues in U2 
stem I with the catalytic traid of U6 snRNA (Fig. 4.4c). As a result, the four-fold 
mutant prevents the formation of helix Ib while maintaining the junction structure of 
the U2-U6 complex. According to the smFRET data, the population of the low 
FRET state significantly decreased with the mutant construct providing additional 
evidence for the low FRET state as the three-helix structure with the helix Ib (Fig. 
4.4d).      
 To further characterize the structural dynamics of the human U2-U6 snRNA 
complex, the folding rate constants (k1, k-1, k2 and k-2) were obtained by dwell time 
analysis (Fig. 4.5). Folding rate constants k1, k-1, and k-2 did not show significant 
changes with varying Mg2+ concentrations (p>0.02). However, the folding rate 
constant k2 increased by ~2-fold (p<0.02) when Mg2+ concentration increased from 
10 mM to 40 mM (Fig. 4.5b).  
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Figure 4.5 The folding pathway and dynamics of human U2-U6 complex. a. 
Proposed two-step minimal folding pathway of the human U2-U6 snRNA complex 
consisting of 3 states: the low FRET state (FRET ~ 0.2), the mid FRET state 
(FRET ~ 0.4) and the high FRET state (FRET ~ 0.6). b. Folding dynamics of the 
human U2-U6 snRNA complex in 10 mM and 40 mM Mg2+. Folding rate constants 
of the U2-U6 complex represented by k1, k-1, k2 and k-2.   
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 Taken together, these data indicate that in the absence of post-
transcriptionally modified bases, high concentration of divalent ions facilitates the 
formation of the three-helix structure of the human U2-U6 complex similar to that 
of yeast snRNAs (134).   
4.3.3 Single-molecule detection of the human U2-U6 complex with 
modifications 
 Human U2-U6 snRNA complex contains a large number of 
posttranscriptional modifications in both strands (Fig. 1.9). To understand the 
effect of these modifications on the structural dynamics of the human U2-U6 
complex, we incorporated 2’-O-methylguanosines - Gm at position 11, 12, 19 and a 
pseudouridine at position 15 into U2 stem I (Fig. 4.6a). The human U2-U6 complex 
containing all four modified residues exhibited a similar Mg2+ titration curve and 
Mg2+ dissociation constant (KMg = 2.2 ± 0.2 mM) comparable to that of the 
unmodified spliceosomal RNA construct in ssFRET analysis (Fig. 4.3b). However, 
the final FRET value of the modified construct is slightly higher than the 
unmodified construct in 40 mM Mg2+ sugesting that modifications may destabilize 
the low FRET conformation.           
To reveal the effect of these modified residues in detail, folding dyamics of 
modified RNA constructs were monitored at the single-molecule level (Fig. 4.6). 
The smFRET trajectories of modified human U2-U6 complexes also showed Mg2+-
dependent conformational changes with three FRET states as previously observed 
for the unmodified construct (Fig. 4.6). 
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Figure 4.6 Single-molecule analysis of the modified human U2-U6 complex. 
a. Structure of the post-transcriptionally modified human U2-U6 snRNA complex. 
b. Folding rate constants of the human U2-U6 snRNA complex in 40 mM Mg2+. c 
and d. FRET histograms of the human U2-U6 complex with and without 
modifications in 10 mM and 40 mM Mg2+. 
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Analysis of the FRET histograms shows that the incorporation of modified 
bases in U2 stem I increases the population of the mid FRET state while 
decreasing the population of the low FRET state at both Mg2+ concentrations. 
However, this effect was more prominent in 40 mM Mg2+ than that of 10 mM Mg2+ 
(Fig. 4.6). Overall this data indicate that the above mentioned modifications may 
stabilize the four-helix structure while decreasing the stability of the three-helix 
structure of the U2-U6 complex.     
Comparison of the folding rate constants of the U2-U6 complex with and 
without modifications shows that the folding rate constants k1 and  k-1 did not vary 
significantly with modifications in both magnesium ion concentrations (p>0.02), but 
modified bases directly affect the folding rate constant k2 and  k-2 in 40 mM Mg2+. 
Under high magnesium ion conditions, the human U2-U6 snRNA construct with 
modifications decreases k2 by ~2-fold (p<0.02) and increases k-2 by ~1.5-fold 
(p<0.02). Therefore, modified bases may destabilize the formation of the low 
FRET structure corresponding to the three-helix structure of the U2-U6 complex 
(Fig. 4.6b).     
4.3.4 Characterization of individual modifications in U2 stem I  
 To understand the effect of individual bases on the structural dynamics of 
the U2-U6 complex, single-molecule experiments were performed with U2-U6 
snRNA constructs containing 2’-O-methylguanosine (Gm) at positions 12 (12Gm), 
19 (19Gm), and both 12 and 19 (12Gm + 19Gm) on the U2 snRNA strand (Fig. 4.7).  
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Figure 4.7 Single-molecule FRET histograms of human U2-U6 snRNA 
complexes. a. FRET histogram of the unmodified construct. b. FRET histogram of 
the modified construct containing 2’-O-methylguanosines at positions 11, 12, and 
19, and pseudouridine at position 15. c. FRET histogram of the modified construct 
containing 12Gm and 19Gm. d. FRET histogram of the modified construct 
containing 12Gm. e. FRET histogram of the modified construct containing 19Gm.     
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  U2U6 snRNA Complex ΔΔG (kcal/mol) 
Unmodified 0 
11 Gm + 12 Gm + 19 Gm + 15 ψ 0.53 ± 0.17 
12 Gm + 19 Gm 0.51 ± 0.18 
12 Gm 0.30 ± 0.16 
19 Gm 0.19 ± 0.13 
 
Table 4.1 Difference between calculated free energy changes (ΔΔG) of the 
unmodified and modified human U2-U6 complexes. ΔΔG >0 destabilizes the 
low FRET state. Error associated with ΔΔG was analyzed using the bootstrap 
method. ψ - pseudouridine and  Gm  - 2’-O-methylguanosine.  
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 The influence of post-transcriptional modifications on the structural 
dynamics of RNA was determined by the differences between free energy 
changes (ΔΔG) of the unmodified and modified U2-U6 complexes (Fig. 4.7 and 
Table 4.1). According to the smFRET histograms and free energy calculations, the 
U2-U6 construct containing both 12Gm and 19Gm on the U2 strand showed similar 
behavior to the U2-U6 construct containing all four modified bases described 
earlier. As a result, the pseudouridine in position 15 and the 2’-O-methylguanosine 
at position 11 of the U2 strand did not show an overall effect on the U2-U6 
structural dynamics under these conditions. Furthermore, the spliceosomal RNA 
construct containing individual modifications slightly destabilized the low FRET 
state of the U2-U6 complex compared to the construct without modified bases. 
Therefore, these smFRET data suggest a collective effect of modified bases 
during the destabilization of the three-helix structure of the U2-U6 snRNA 
complex.    
4.4 Discussion 
 The U2-U6 snRNA complex is the main component of the catalytic core of 
the eukaryotic spliceosome. The human U2-U6 snRNA complex can catalyze a 
splicing related reaction in the absence of proteins, providing evidence for the 
catalytic ability of these spliceosomal RNAs (11,13,107). However, the specific 
conformation of the human U2-U6 snRNA complex that triggers the splicing 
reaction is not well understood. Therefore, the human U2-U6 complex was 
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characterized using single-molecule fluorescence to investigate the structural 
dynamics in real time.   
 Consistent with previous studies, our smFRET data suggest that the human 
U2-U6 snRNA complex can act as a Mg2+-dependent conformational switch. 
Similar to single-molecule folding dynamics of yeast U2-U6 snRNAs (134), human 
U2-U6 snRNA complexes without post-transcriptionally modified bases in the U2 
stem I show the presence of at least three distinct FRET states in dynamic 
equilibrium corresponding to different structural conformations (Fig. 4.5). Based on 
sequence similarities between human and yeast spliceosomal RNAs and 
mutational studies, the observed FRET states have been assigned as the three-
helix structure (FRET ~0.2), the four-helix structure (FRET ~0.6), and the 
previously unidentified intermediate structure (FRET ~0.4).  
 Considering the positions of the FRET donor and acceptor fluorophores, we 
propose that the highly conserved ACAGAGA sequence and the magnesium 
binding site U-74 in U6 ISL are in close proximity in the high FRET state. 
Therefore, the high FRET state resembles the four-helix structure with the 
extended U6 ISL containing the AGC triad proposed by NMR studies (Fig. 4.5). 
Furthermore, this structure supports the important properties of the active 
conformation exhibiting close association of the highly conserved regions that 
have been shown to participate in the splicing reaction. 
 In high magnesium concentrations, the U2-U6 complex prefers the low 
FRET state, which has two fluorophores far away from each other. As we 
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previously observed in yeast, the human U2-U6 complex can also adopt the three-
helix structure with helix Ib by rearranging the junction structure (Fig. 4.5). The 
existence of the three-helix structure with helix Ib was further confirmed using a 
four-fold mutant that prevents the formation of helix Ib (Fig. 4.4). Although it can 
maintain the junction structure, this mutant construct containing the flipped bases 
in the U2 stem I greatly decreases the low FRET state population providing a 
direct evidence for this conformation as the previously proposed three-helix 
structure.      
 In addition to the conformations discussed above, smFRET data of U2-U6 
snRNAs exhibited the existence of a previously unidentified folding intermediate 
with FRET ~ 0.4. Since previous studies have shown that the stability of this 
conformation is independent of the mutations at U-80 in yeast (comparable to U-
74 in humans) U6 snRNA, we propose this mid FRET state has the extended U6 
ISL structure, but lacks the tertiary interactions between the ACAGAGA sequence 
and the U6 ISL (Fig. 4.5). However, the role of this conformation in pre-mRNA 
splicing is not well understood in both humans and yeast.  
 Consistent with yeast smFRET data (134), the population of low FRET state 
(FRET ~0.2) increases with Mg2+ concentration indicating a magnesium-mediated 
stabilization of the low FRET state. As a result, under high Mg2+ concentrations, 
the human U2-U6 complex without post-transcriptionally modified bases showed a 
higher population of molecules in the low FRET state than the higher FRET states.  
 
118 
 
 
 
In contrast, the human U2-U6 snRNAs with modified bases in U2 stem I (11Gm, 
12Gm, 19Gm and pseudouridine at position 15) show a clear stabilization effect of 
the mid FRET state while lowering the population of the low FRET state 
corresponding to the three-helix structure (Fig. 4.6).  
Interestingly, smFRET data obtained from the U2-U6 construct with 2’-O-
methylguanosines at positions 12 and 19 (12Gm + 19Gm) exhibited similar folding 
dynamics to the fully modified construct (Fig 4.7 and Table 4.1). Therefore, these 
results suggest that 11Gm and pseudouridine at position 15 of U2 stem I do not 
exhibit an overall effect on the folding dynamics of the U2-U6 complex. This 
unique behavior can be due to either cancellation of opposite effects or due to lack 
of direct stabilization/destabilization effect from the two individual modifications. 
Furthermore, the human U2-U6 complex with individual modifications (12Gm or 
19Gm) showed only a slight destabilization effect on the low FRET state compared 
to the U2-U6 complex without modified bases (Table 4.1).   
 Taken together, the smFRET data suggest that modified bases collectively 
affect the structural dynamics of the U2-U6 complex by stabilizing U2 stem I. Thus, 
these modifications may prevent the formation of the three-helix structure 
consisting of helix Ib. Although the modified bases destabilize the low FRET state, 
the effect of modifications on the stability of U2 stem I is less significant in the U2-
U6 complex than in the U2 stem I alone as shown in UV melting studies (118). 
Therefore, we propose that post-transcriptionally modified residues may be 
involved in protein recognition and interactions rather than the direct stabilization 
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of U2-U6 RNA structures in vivo. Additionally, these modified bases may 
participate in structural stabilization during the early assembly of the spliceosome 
as suggested previously (156).     
4.5 Conclusions 
 Nuclear pre-mRNA splicing is an essential process in eukaryotic gene 
expression that is catalyzed by a large RNA-protein complex known as the 
spliceosome. Although the spliceosome consists of five snRNAs and more than 
150 proteins (98), previous studies have shown that the spliceosomal U2 and U6 
snRNAs interact with the pre-mRNA and are the primary contributors to the 
formation of the spliceosomal catalytic core. Therefore, the U2-U6 snRNA complex 
plays a critical role in pre-mRNA splicing in all eukaryotes (11,13,107).  
 To elucidate the conformations of the U2-U6 snRNA complex involved in 
the splicing reaction, the spliceosomal U2-U6 RNAs have been characterized 
using various genetic and biochemical methods. Initial genetic studies have 
suggested the human U2-U6 complex also adopts the three-helix structure to 
mediate the splicing reaction as observed in yeast (116). However, genetic 
complementation studies have shown residues involved in the formation of the 
helix Ib prefer to form intramolecular base pairing rather than intermolecular base 
pairing between human U2 and U6 snRNAs (117). Thus, they proposed human 
U2-U6 snRNAs form the four-helix structure similar to the yeast U2-U6 complex 
proposed by NMR studies (108,117). As a result of these two contradicting views, 
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the structure of the U2-U6 complex participating in pre-mRNA splicing is not well 
understood.  
 Although it has been hypothesized, the ability of the U2-U6 complex to 
adopt at least two different conformations corresponding to different activation 
states has not been well characterized experimentally. In order to address this 
issue, we used single-molecule prism-based TIRF microscopy to characterize the 
dynamics of human spliceosomal RNAs. Our single-molecule fluorescence studies 
of human spliceosomal RNAs show that both previously proposed structures are 
not only present, but also in a dynamic equilibrium in the presence of magnesium 
ions similar to yeast U2-U6 complex (134). In addition, single-molecule data 
indicate the presence of at least one obligatory intermediate conformation in the 
U2-U6 folding pathway. Furthermore, we suggest the three-helix structure of the 
human U2-U6 complex contains helix Ib, which forms between the catalytic triad of 
U6 snRNA and U2 stem I residues.      
 One of the major differences between human and yeast spliceosomal RNAs 
is the presence of several post-transcriptional modifications in human snRNAs 
compared to yeast snRNAs (118). To understand the effect of these modifications 
on structural dynamics, single-molecule experiments were performed in the 
presence of modifications in U2 stem I. Although the U2-U6 complex without these 
modifications shows the similar behavior to yeast, the spliceosomal RNAs 
containing modified bases destabilize the low FRET state while increasing the 
population of the mid FRET state. However, the comparison of free energy 
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calculations based on the smFRET data and UV melting data (118) suggests 
modified bases may involve in different functions such as protein recognition 
and/or early assembly of the spliceosome in vivo (156), but not in direct 
stabilization of RNA structures.    
 In summary, the human U2-U6 complex follows the minimal two-step 
folding pathway consisting of the previously proposed two structures and at least 
one obligatory intermediate conformation. Furthermore, RNA constructs without 
post-transcriptionally modified bases exhibited similar dynamics as yeast 
spliceosomal RNAs (134). Although modified bases can affect the structural 
dynamics of human U2-U6 snRNAs, the structural effects of the U2-U6 complex 
were less than that of U2 stem I alone (118) suggesting a different role rather than 
direct stabilization of RNA structures in cells.  
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CHAPTER 5  
An RNA Aptamer Based Purification System for Fluorophore 
Labeled Proteins 
5.1 Introduction  
 RNA-protein interactions play an essential role in living organisms. These 
interactions are involved in the regulation of various processes including mRNA 
splicing, translation and RNA maturation. In order to properly understand the 
regulating mechanisms, it is important to directly study the RNA-protein 
interactions by genetic, biochemical and biophysical approaches (157). 
Considering fluorescence-based techniques have proven very useful in studying 
the structure and function of biomolecules (36), researchers have recently utilized 
fluorescently-labeled proteins in the investigation of complex biological processes 
both in vitro and in vivo (158-160).  
 Although a variety of methods for fluorophore labeling proteins of interest 
are available (158), these methods are rarely 100% efficient and often result in 
mixtures of labeled and unlabeled proteins. Unlabeled proteins in solution pose a 
problem in fluorescence assays because they act as competitors to their labeled 
counterparts. This competition challenges the ability to conduct kinetic and 
thermodynamic analyses by fluorescence. Further purifying fluorophore-labeled 
proteins can be particularly challenging if the protein denatures easily. In order to 
overcome all of these challenges, we have developed an efficient method to 
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separate fluorophore labeled proteins from unlabeled proteins under non-
denaturing conditions.  
 Many analytical methods are based on molecular recognition. RNA 
aptamers exhibit interesting molecular recognition properties by binding a desired 
ligand with high affinity and specificity (161). Aptamers can bind a wide range of 
target molecules ranging from large protein domains, such as the HIV-1 
nucleocapsid protein (162), to small organic molecules, such as the fluorophore 
Malachite Green (163), with dissociation constants that often range from 
micromolar to low picomolar (164,165). These qualities make RNA aptamers ideal 
molecular recognition tools in analytical, diagnostic and therapeutic applications.  
 With the development of SELEX (Systematic Evolution of Ligands by 
Exponential Enrichment), an in vitro selection tool, it is possible to quickly isolate 
and amplify oligonucleotide sequences that specifically bind a desired ligand 
(161,166). SELEX involves repeating cycles of a selective binding followed by an 
amplification (Fig. 5.1). The process begins with the synthesis of a single-stranded 
library of oligonucleotides containing a central region of random sequence flanked 
by a 5’ and 3’ region of defined sequences. Since all members of the library 
contain a unique sequence, the complexity of the synthetic library depends on the 
number of randomized nucleotides in the central region. During the selection 
process, the pool of random oligonucleotides is first incubated with the desired 
target ligand and then the high-affinity binding sequences are separated from non-
specific or low-affinity binding sequences by methods such as affinity 
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chromatography (161) or, more recently, high efficiency electrophoretic methods 
(167). The oligonucleotide sequences exhibiting high affinity for the target 
molecules are amplified by RT-PCR (for RNA) or PCR (for DNA).  Since PCR 
methods yield double stranded oligonucleotide products, an additional step is 
required to produce a single-stranded oligonucleotide library enriched with high-
affinity sequences for the next selection cycle.     
 RNA aptamers display remarkably high affinity and selectivity for their target 
ligands compared to those of some monoclonal antibodies (168). Thus aptamers 
can be considered a valid alternative to antibodies or other bio-mimetic receptors. 
Moreover, chemically synthesizable aptamers possess several advantages over 
antibodies making them a promising alternative in the field of affinity 
chromatography (136,169). Roming and co-workers have developed an aptamer 
specific to L-selectin to purify human L-selectin receptor globulin (LS-Rg) fusion 
protein (170). Deng et al. used an aptameric stationary phase to monitor the level 
of adenosine in the brain of live rats (171).  
 The above-mentioned experiments demonstrate that aptamer-
chromatographic methods provide a valid alternative to other methods such as 
HPLC. Consequently, we have taken advantage of the specific properties of 
aptamers to develop an aptamer-based affinity purification method to purify 
fluorophore-labeled proteins.   
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Figure 5.1 Scheme of in vitro selection of oligonucleotide aptamers by 
SELEX. The first step involves the generation of a large pool of random 
oligonucleotide sequences. After incubating these sequences with target 
molecules, high affinity binding sequences can be separated from non-specific 
species. Then these specific sequences can be amplified by Polymerase Chain 
Reaction (PCR) to make a new enriched library for the next cycle.  
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Tetramethylrhodamine (TAMRA) is a common fluorophore in numerous 
fluorescence-based assays (172,173). Therefore, we have chosen this fluorophore 
as a model to show that RNA aptamers can be used to purify fluorophore-labeled 
proteins. Previous work has identified an RNA aptamer, SRB-2, which binds 
sulforhodamine B tightly and selectively (KD = 310 nM). SRB-2 is a 54 nucleotide 
RNA aptamer that binds the fluorophore by recognizing both its planar aromatic 
ring system and its negatively-charged sulfonate group at the ortho position (174). 
Strong similarities in the structure of sulforhodamine and the more commonly 
employed tetramethylrhodamine species suggest that this aptamer would suitable 
for binding TAMRA (Fig. 5.2). Discussed here is a method by which the affinity of 
SRB-2 for TAMRA is applied to the purification of TAMRA-labeled maltose binding 
protein (MBP). 
5.2 Experimental design 
 In order to develop an efficient chromatographic method for purification of 
fluorophore-labeled proteins from the unlabeled fraction under mild reaction 
conditions, we wanted to construct an affinity purification column using an aptamer 
RNA specific for the given fluorophore.  
 Fluorescence anisotropy is a widely used fluorescent-based technique that 
detects the binding of molecules with fluorophores based on the rotational 
diffusion of a molecule. Therefore, the specificity and binding properties between 
the aptamer and the fluorophore of interest were characterized using fluorescence 
anisotropy under specific buffer conditions as explained in the methods section.       
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Figure 5.2 Structure of SRB-2 aptamer and fluorophores a. Secondary 
structure of the SRB-2 aptamer. The aptamer consists of a three-way helical 
junction with two large unpaired regions. The 3’-end is biotinylated for column 
immobilization. b. Structure of sulforhodamine B (SRB) c. The subject ligand, 
tetramethylrhodamine (TAMRA), contains a 3-ring aromatic system and a meta-
positioned carboxylate group that have previously been shown to be recognized 
by the SRB-2 aptamer. 
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After optimizing the binding and elution conditions for the SRB-2 aptamer 
and tetramethylrhodamine, an affinity chromatographic column was constructed 
using biotin-labeled SRB-2 aptamer and streptavidin coated 6% crosslinked 
agarose beads (Fig. 5.2). To characterize the specific activity of this assay, 
tetramethylrhodamine-labeled maltose binding protein was purified using an SRB-
2 aptamer based affinity chromatographic column under optimized reaction 
conditions.            
5.3 Results and Discussion 
5.3.1 SRB-2 binds TAMRA with high affinity and specificity  
 We first tested the ability of the SRB-2 aptamer to bind TAMRA by 
fluorescence anisotropy. Fluorescence anisotropy reports on the rotational 
freedom of the fluorophore, and therefore, we expect to observe a significance 
increase in TAMRA fluorescence anisotropy upon binding the RNA aptamer. 
Figure 5.3 shows the fluorescence anisotropy of 250 nM TAMRA as a function of 
SRB-2 concentration. In the absence of SRB-2, the observed anisotropy of the 
TAMRA was very low (0.04 ± 0.01), indicating that TAMRA can rotate freely in 
solution. In the presence of 500 nM aptamer, the fluorescence anisotropy 
increases to 0.24 ± 0.01. This high anisotropy value suggests the aptamer has 
bound the fluorophore and restricts its free rotation. A fit to an SRB-2 titration (Eq. 
6, page 60) provides a dissociation constant KD = 15 ± 6 nM, indicating that SRB-2 
binds TAMRA tighter than sulforhodamine B for which it was initially selected (KD ≈ 
310 nM) (174).  
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Figure 5.3 Fluorescence anisotropy value as a function of SRB-2 
concentration. Circles represent the binding of the SRB-2 aptamer and squares 
represent the binding of control RNA with TAMRA indicating specificity for the 
TAMRA ligand by SRB-2. Solid line represents the binding curve, fitting to 
Equation 6 (page 60) results in a dissociation constant KD = 15 ± 6 nM. All 
anisotropy measurements were done in buffer conditions: 100 mM KCl, 5 mM 
MgCl2, 10 mM Na-HEPES, pH 7.4 with 250 nM rhodamine. 
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 The binding specificity of SRB-2 for TAMRA was further tested by 
anisotropic titration of a negative control RNA sequence (36 nucleotides) under 
identical buffer conditions (Fig. 5.3).  No appreciable change in TAMRA anisotropy 
was observed with increasing RNA concentrations. We also measured the kinetics 
of the SRB-2/TAMRA complex formation by monitoring the fluorescence 
anisotropy increase as a function of time. Our results show that the fluorescence 
anisotropy increases faster than our time resolution (<10 s, data not shown), 
indicating that the complex forms rapidly. These results show that SRB-2 binds 
TAMRA with high affinity and specificity, and thus this aptamer is suitable to 
develop an affinity purification assay for TAMRA-labeled proteins. 
5.3.2 SRB-2 binding can be regulated by Mg2+ ions and EDTA 
 The SRB-2 aptamer requires the presence of magnesium ions to bind its 
ligand (174). To control binding and dissociation from the aptamer, we sought to 
use Mg2+ ions and EDTA, respectively. First, we determined the Mg2+ ion 
requirement for SRB-2 binding TAMRA by measuring the TAMRA fluorescence 
anisotropy as a function of Mg2+ concentration. Figure 5.4a shows the 
fluorescence anisotropy of 250 nM TAMRA in the presence of saturating SRB-2 
(500 nM) in selection buffer and as a function of [Mg2+]. In the absence of Mg2+, 
the initial anisotropy is 0.04 ± 0.01, comparable to that of free TAMRA, indicating 
that in the absence of Mg2+ ions, the aptamer does not fold into its functional 
structure and thus, it cannot bind TAMRA.  
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Figure 5.4 Effect of Mg2+ and EDTA concentrations on binding of SRB-2 
aptamer with TAMRA. a. TAMRA fluorescence anisotropy as a function of Mg2+ 
concentration. Anisotropy was measured in solutions containing 100 mM KCl, 10 
mM Na-HEPES, pH 7.4, 250 nM TAMRA and 500 nM SRB-2 at different 
concentrations of Mg2+. The data indicates a significant Mg2+-binding dependence, 
a property easily exploited for elution of bound ligands.  Curve fitting to Equation 7 
(page 60) results in a dissociation constant KMg = 0.19 ± 0.03 mM. b. TAMRA 
fluorescence anisotropy as a function of EDTA concentration. The effect of EDTA 
on binding of SRB-2 with TAMRA was determined by measuring the anisotropy in 
solutions containing 100 mM KCl, 5 mM MgCl2, 10 mM Na-HEPES, pH 7.4, 250 
nM TAMRA and 500 nM SRB-2 aptamer. Curve fitting to Equation 8 (page 60) 
results in KEDTA = 4.0 ± 0.1 mM and co-operativity coefficient, n = 7 ± 1.   
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Addition of 5 mM Mg2+ results in an anisotropy increase to 0.24 ± 0.01, 
comparable to that of fully bound TAMRA, indicating that in the presence of Mg2+ 
ions SRB-2 is capable of binding TAMRA. A fit to a Mg2+ titration (Eq. 7, page 60) 
yields a KMg = 190 ± 30 µM indicating the presence of a strong magnesium ion 
binding site that is important for TAMRA binding.  
Next, we sought to characterize the amount of EDTA required to release 
TAMRA from the aptamer by measuring its fluorescence anisotropy in the 
presence of SRB-2 and 5 mM Mg2+, and as a function of EDTA concentration (Fig. 
5.4b). In the absence of EDTA, the initial anisotropy is rmax = 0.24 ± 0.01, 
indicating that TAMRA is fully bound. Addition of 5 mM EDTA, results in an 
anisotropy decrease to r0 = 0.05 ± 0.01, indicating that EDTA has chelated the 
Mg2+ ions in solution, thus unfolding the aptamer, which in turn releases TAMRA in 
solution.  
A fit to the resulting EDTA titration (Fig. 5.4b, Eq. 8, page 60) results in a 
KEDTA = 4.0 ± 0.1 mM and a cooperativity coefficient, n = 7 ± 1.  This coefficient 
indicates that chelation of RNA-bound Mg2+ by EDTA is a highly cooperative 
process and suggests that the aptamer unfolds as Mg2+ ions become more loosely 
bound to the RNA.  These results show that TAMRA binding to the SRB-2 aptamer 
and release can be readily regulated under mild, non-denaturing conditions by 
simply regulating the [Mg2+] in solution with EDTA.  
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5.3.3 RNA aptamer affinity purification of a TAMRA labeled protein 
 After optimizing the binding conditions, we fluorophore-labeled maltose 
binding proteins (MBP) with TAMRA and sought to purify the labeled protein by 
SRB-2 aptamer-based affinity chromatography. In order to perform the purification 
assay, fluorophore-labeled protein was added to a column containing SRB-2 
aptamer bound agarose beads. Fluorophore-labeled MBP was purified and eluted 
using both washing and elution buffers as described in materials & methods. The 
column washings and elutions were analyzed by UV-Visible absorbance as well as 
by fluorescence emission spectroscopy (Fig. 5.5).   
 Figure 5.5a shows the trend of UV absorbance at 280 nm as a function of 
column volume, indicating the presence of the maltose binding protein in solution. 
Fractions labeled P1 through P5 (Fig. 5.5, green bars) of those column volumes 
eluted in aptamer binding conditions (100 mM KCl, 5 mM MgCl2, 10 mM Na-
HEPES, pH 7.4) intended to remove unlabeled proteins from the column. Those 
labeled E1 through E5 (Fig. 5.5, red bars) represent the volumes taken in EDTA 
elution conditions (5 mM EDTA, 100 mM KCl, 10 mM Na-HEPES, pH 7.4) 
intended to remove bound TAMRA-labeled proteins. A significant increase in UV 
absorbance at 280 nm is observed at volume P2, which diminishes in the following 
three column volumes.  An increase in UV absorbance is seen at volumes E2 and 
E3. Clearly two populations of protein are removed from the column: one under 
aptamer binding conditions and another under elution conditions.  
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Figure 5.5 RNA aptamer affinity purification of a TAMRA labeled protein. a. 
UV absorbance at 280 nm as a function of column volume.  Volumes labeled P1 
through P5 are the result of column washings in binding conditions intended to 
remove unlabeled proteins, whereas those labeled E1 through E5 are the result of 
EDTA elutions intended to remove TAMRA-labeled proteins from the aptamer. The 
significant increases in UV absorbance in P2, P3 and E2, E3 indicate two distinct 
populations of protein being eluted from the column. b. UV-Vis absorbance at 550 
nm as a function of column volume. The significant increase in UV-Vis absorbance 
at E2 indicates the elution of the TAMRA fluorophore with EDTA elution buffer. c. 
Ratio of fluorophore concentration to protein concentration as a function of column 
volume. The concentration ratios, determined by UV analysis, are approximately 
1:1 in elutions E2 through E4, indicating the elution of singly labeled proteins. d. 
Fluorescence emission intensity as a function of column volume.  The increase in 
fluorescence emissions at E2 verifies the elution of the TAMRA fluorophore with 
EDTA elution buffer. 
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Figure 5.5b shows the UV-Vis absorbance at 550 nm of the same column 
volumes as above, indicating the presence of the TAMRA fluorophore species.  A 
small baseline value for volumes P1 through P5 may indicate a small percentage 
of fluorophore-labeled proteins binding on part of the immobilized SRB-2. A 
significant increase of UV absorbance is observed at volumes E2 and E3, and 
congruent with the previous figure, indicates the elution of TAMRA-labeled protein 
in these volumes.  
 Figure 5.5c shows the ratio of concentrations of the TAMRA fluorophore to 
those of the MBP protein in successive column volumes calculated from the 
absorbance data presented in Figures 5.5a and b. Values smaller than 1 in 
volumes P1 through P5 show an abundance of MBP with respect to TAMRA, 
indicating predominantly unlabeled proteins present in solution, whereas values 
approximately equal to 1 seen in elution E2-E4 indicate the fraction of the singly 
TAMRA-labeled MBP proteins.  
 The data presented in Figure 5.5d, fluorescence emission intensity (λex = 
555 nm, λem = 580 nm) as a function of elution fraction, compliments the data 
presented in Figure 5.5b. An increase in fluorescence emission intensity at E2 and 
E3 indicates that the rise in UV absorbance seen in Figure 5.5b is in fact brought 
about by the elution of the TAMRA fluorophore species in the respective column 
volumes. 
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5.4 Conclusions  
 With the objective of isolating fluorophore labeled-proteins from mixtures of 
labeled and unlabeled proteins such as those resulting from inefficient labeling 
reactions, we have developed a purification method based on an RNA aptamer 
specific to the fluorophore species. The modified maltose binding protein (MBP) 
labeled with the tetramethylrhodamine (TAMRA) fluorophore species by a 
cysteine-maleimide reaction has been effectively isolated from unlabeled MBP by 
passing the mixture through an affinity chromatographic column containing 
sulforhodamine binding aptamer (SRB-2) immobilized by a biotin-streptavidin 
interaction (Fig. 5.2).  
 The binding of SRB-2 to the TAMRA fluorophore species was first 
characterized, and then binding and elution conditions optimized by a fluorescence 
anisotropic assay (Figs. 5.3 and 5.4). Following such characterizations, the 
aptamer was 3’-biotinylated and immobilized in an LC column bed of streptavidin-
coated agarose beads. The column elutions were analyzed by UV-Visible and 
fluorescence spectrophotometry for their protein and fluorophore contents (Fig. 
5.5). The result is a well-resolved separation of fluorophore-labeled proteins from 
identical proteins, which were not effectively labeled in the labeling reaction. The 
majority of labeled proteins eluted over only two column volumes. 
 The method described herein poses several unique advantages for the 
purification of fluorophore labeled proteins.  Certainly the primary advantage of this 
approach is the ability to purify protein samples in native buffer and pH conditions.  
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The benefit of this method is that it ensures the purified protein will not have been 
denatured, thus preserving the structure and function of the subject protein.  
Another advantage of this method is its inherent versatility. The growing field of 
aptamer chemistry continues to identify new aptamer-ligand systems.  Therefore, 
this method may be easily expanded to purify proteins modified in vitro by other 
labeling reactions. Furthermore, this method may be useful in the isolation of 
proteins modified in vivo by employing aptamers selected against substrates of 
such modifications. Finally, adaptations of this method to employ DNA aptamers 
may yield highly stable affinity purification systems with extended shelf lives. 
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CHAPTER 6  
Conclusions and Future Directions 
 Single-molecule fluorescence has a unique ability to characterize RNA 
folding pathways by identifying transient intermediates in real times that can be 
otherwise hidden in ensemble-averaged experiments (36). Therefore, the folding 
pathway of group II introns and the effect of Mss116 DEAD box proteins on group 
II intron folding as well as the dynamics of the human U2-U6 spliceosomal RNA 
complex were characterized using the TIRF-based single-molecule microscopy 
(37). 
 Group II introns can self-splice in vitro under high ionic strength conditions. 
Previous single-molecule studies have been able to successfully characterize the 
three-step folding pathway of group II introns under these optimum in vitro splicing 
conditions (68). However, in vivo, the splicing of group II introns is primarily 
assisted by protein cofactors such as the Mss116 DEAD-box protein. Biochemical 
and folding studies (80,87-89,92) have proposed that Mss116 can promote group 
II intron splicing by stabilizing on-pathway intermediates and/or by disrupting 
misfolded structures. However, the exact mechanism of protein-mediated splicing 
is still debatable.  
 Previous studies have revealed that the yeast group II intron ai5γ can form 
a catalytically active native structure through a slow but smooth folding pathway 
devoid of kinetic traps (80,87). Furthermore, it has been shown that a helicase-
deficient Mss116 mutant still retains the ability to promote group II intron splicing 
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(88,89,155). Based on these observations, it has been suggested that Mss116 
catalyzes splicing by stabilizing the RNA structures. In contrast, some evidence 
supports a mechanism by which Mss116 unwinds kinetic traps to assist splicing, 
even at low levels of helicase activity (88,89). Both proposed mechanisms, 
however, are primarily based on indirect studies of ai5γ group II intron splicing. To 
address this issue, a single-molecule fluorescence assay has been used to 
characterize the effect of Mss116 on ai5γ folding by directly monitoring the 
influence of Mss116 and ATP on group II intron folding (37).  
 Group II introns alone cannot reach the catalytically active native state 
under near-physiological conditions. According to single-molecule studies, large 
energy barriers between states prevent the formation of the native state under 
these conditions in the absence of protein cofactors. However, the DEAD-box 
protein Mss116 or non-specific basic RNA binding proteins can lower the 
activation barriers and promote the folding of intron RNA to the active native state. 
Although transitions from the extended intermediate state to the folded 
intermediate state are independent from the ATP hydrolysis, the binding and 
hydrolysis of ATP is required for efficient formation of the native state under these 
conditions as illustrated in the free-energy diagram (Fig. 3.12) (37).  
 In summary, Mss116 has multiple roles in the folding pathway of 
ai5γ. Based on smFRET data, we propose that Mss116 mediates group II intron 
folding by stabilizing on-pathway intermediates upon transition from the unfolded 
state to the folded state. However, we also observe that the transition from the 
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folded intermediate state to the native state requires ATP hydrolysis. Taken 
together, we propose a three-step folding pathway for ai5γ in the presence of 
Mss116 and ATP. First, unfolded group II intron ribozymes (U) slowly collapse to 
the extended intermediate state (I) under near physiological conditions, as 
previously observed (87). As expected, this transition is so slow that we did not 
observe it in our experiments. The extended intermediate can interact with Mss116 
to further compact this state. Next, Mss116 (or other proteins) induces formation of 
the folded intermediate (F). Finally, the native state is stably formed once ATP is 
hydrolyzed, possibly upon Mss116 release. Our data also show that the presence 
of substrate further stabilizes the native state, raising the interesting possibility that 
in vivo and in the presence of all the group II intron domains and Mss116, the 
native state becomes the most stable conformation (37). 
 In order to confirm the proposed Mss116-mediated folding pathway, we are 
planning to monitor the folding of group II introns using the fluorophore-labeled 
Mss116. Thereby, we can simultaneously detect the RNA folding and the 
interactions between the RNA and the protein in vitro. Furthermore, the single-
molecule assay can be used to understand the effect of the other DEAD-box 
proteins such as CYT19 and Deb1 on the folding of group II introns. Finally, this 
assay will allow us to characterize the essential structural interactions of group II 
introns using mutant ai5γ constructs. 
 The structure and catalytic mechanism of group II introns are analogous to 
the spliceosome-catalyzed nuclear pre-mRNA splicing in eukaryotes (57). 
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Although the spliceosome consists of five snRNAs and more than 150 proteins, 
previous studies have shown that the spliceosomal U2 and U6 snRNAs interact 
with the pre-mRNA and are the primary contributors to the formation of the 
spliceosomal catalytic core. Therefore, the U2-U6 snRNA complex plays an 
important role in pre-mRNA splicing in all eukaryotes (11,13,107).  
 In order to understand the structural role of the U2-U6 snRNA complex in 
the splicing reaction, the spliceosomal U2-U6 RNAs have been characterized 
using various genetic and biochemical methods. Initial genetic studies have 
suggested the human U2-U6 complex can adopt a three-helix structure to mediate 
the splicing reaction as observed in yeast (116). However, genetic 
complementation studies have shown residues involved in the formation of helix Ib 
prefer to form intramolecular base pairing rather than intermolecular base pairing 
between human U2 and U6 snRNAs (117). Thus, they proposed human U2-U6 
snRNAs form the four-helix structure similar to the yeast U2-U6 complex proposed 
by NMR studies (108,117). As a result of these conflicting views, the catalytically 
active structure of the human U2-U6 complex participating in pre-mRNA splicing is 
not well understood.  
 It has been hypothesized that the U2-U6 complex can adopt different 
conformations corresponding to different activation states; however, these 
dynamics have not been well characterized experimentally. In order to address 
this issue, we used single-molecule prism-based TIRF microscopy to characterize 
the dynamics of human spliceosomal RNAs. Our single-molecule fluorescence 
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studies of human spliceosomal RNAs show that both previously proposed 
structures are not only present, but also in a dynamic equilibrium in the presence 
of magnesium ions similar to yeast U2-U6 complex (134). In addition, single-
molecule data indicate the presence of at least one obligatory intermediate 
conformation in the U2-U6 folding pathway. Furthermore, we suggest the three-
helix structure of the human U2-U6 complex contains helix Ib, which forms 
between the catalytic triad of U6 snRNA and U2 stem I residues.      
 One of the major differences between human and yeast spliceosomal RNAs 
is the presence of several post-transcriptional modifications in human snRNAs 
compared to yeast snRNAs (118). To understand the effect of these modifications 
on structural dynamics, single-molecule experiments were performed in the 
presence of a few important modifications in U2 stem I (2’-O-methylguanosines - 
Gm at positions 11, 12 and 19, and pseudouridine at position 15). Although the U2-
U6 complex without these modifications shows similar behavior to yeast, the 
spliceosomal RNAs containing modified bases destabilize the low FRET state 
while increasing the population of the mid FRET state. However, comparison of 
free energy calculations from smFRET data and UV melting data (118) suggests 
modified bases may be involved in different functions such as protein recognition 
and early assembly of the spliceosome (156), but not in direct stabilization of RNA 
structures.    
 In summary, the human U2-U6 complex follows the minimal two-step 
folding pathway consisting of the previously proposed two structures and at least 
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one obligatory intermediate conformation. Furthermore, RNA constructs without 
post-transcriptionally modified bases exhibited similar dynamics as yeast 
spliceosomal RNAs (134). Although modified bases can affect the structural 
dynamics of human U2-U6 snRNAs, the structural effects of the modified bases on 
the U2-U6 complex were less than the effects on the U2 stem I alone (118). This 
suggests the modified bases may have an alternative role besides direct 
stabilization of RNA structures in cells. Therefore, we propose modified bases 
predominantly participate in protein recognition and/or early assembly of the 
spliceosome (156)  rather than direct stabilization of the U2-U6 snRNA complex in 
vivo.  
 In order to further understand the structural dynamics of spliceosomal U2-
U6 snRNAs that are essential for pre-mRNA splicing and to clarify the specific role 
of post-transcriptionally modified bases of snRNAs in splicing, we can monitor the 
dynamics of the fluorophore-labeled U2-U6 snRNA complex in the presence of the 
cell extract containing all necessary spliceosomal components. Furthermore, these 
experiments will provide an opportunity to monitor the pre-mRNA splicing in real 
time revealing fundamental structural rearrangements between RNA and protein 
components in the spliceosome.     
 Overall, we were able to successfully combine FRET with single-molecule 
detection to dissect RNA splicing mechanisms. In the process, we revealed the 
role of Mss116 DEAD-box protein on the group II intron folding pathway and 
monitored structural dynamics of human U2-U6 snRNAs that are essential for pre-
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mRNA splicing in vitro. Characterization of these fundamental splicing 
mechanisms in eukaryotes will not only expand the existing knowledge in the 
splicing field, but also pave the way for future research. 
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 Group II introns rank amongst the largest self-splicing ribozymes found in 
bacteria and organellar genomes of various eukaryotes. Interestingly, these 
ribozymes can self-splice via two transesterification reactions that resemble 
nuclear pre-mRNA splicing in eukaryotes (54,55). Despite the diversity in primary 
sequences, group II introns posses highly conserved secondary structures 
consisting of six domains (D1-D6). To perform its function, the large multidomain 
group II intron RNA must adopt the correctly folded structure (52). As a result, in 
vitro splicing of these introns requires high ionic strength and elevated 
temperatures. In vivo, this process is mainly assisted by protein cofactors (37).  
However, the exact mechanism of protein-mediated splicing of group II intron RNA 
is still not known.  
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 In order to elucidate the mechanism of protein-mediated splicing of group II 
introns, we have studied the folding dynamics of the D135 ribozyme, a minimal 
active form of the yeast ai5γ group II intron, in the presence of its natural cofactor, 
the DEAD-box protein Mss116, using single-molecule fluorescence. Consistent 
with folding studies at very high magnesium concentrations, our single-molecule 
data show that Mss116 can promote the folding of group II introns under near 
physiological conditions in vitro. Furthermore, smFRET data indicate that the 
Mss116-mediated group II intron folding pathway is a multi-step process that 
consists of both ATP-independent and ATP-dependent steps (37).  
 Structurally and mechanistically group II introns are similar to spliceosome-
catalyzed pre-mRNA splicing. Out of five snRNAs, only the highly conserved U2 
and U6 snRNAs are required in both steps of RNA splicing. The U2-U6 snRNA 
complex forms the active site of the spliceosome and has been shown to undergo 
splicing-related catalysis in the absence of proteins (11,13,107). Single-molecule 
studies of yeast U2-U6 snRNAs show a Mg2+ induced conformational change, 
which may be involved in spliceosomal activation in vivo (134). In contrast to 
yeast, human U2 and U6 snRNAs contain a large number of post-transcriptional 
modifications. Recent studies have shown these modifications make human 
snRNAs more stable than that of yeast indicating a possibility of having different 
spliceosomal activation states. 
 In order to understand and compare the catalytic mechanisms, we used 
single-molecule florescence to characterize the conformational changes of human 
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U2-U6 complex in the presence and absence of modifications using Mg2+ as a 
divalent metal ion. Our FRET data clearly show a Mg2+ induced conformational 
change with three FRET states. Based on smFRET data, we propose a minimal 
two-step folding pathway for human snRNAs similar to yeast. Although unmodified 
snRNAs exhibit similar folding dynamics as yeast (134), modified bases 
destabilize the low FRET state of the U2-U6 complex. However, comparison of 
FRET and UV melting data (118) suggests modified bases may be involved in 
protein recognition and/or early assembly of the spliceosome rather than direct 
stabilization of RNA structures in vivo.    
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